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The pyrrolidine ring is present in a large number of alkaloid natural products and in many 
pharmaceutical drugs. Building on the asymmetric ‘Clip-Cycle’ synthesis of spiropyrrolidines, this 
thesis details our study into the kinetic resolution of racemic ‘Clip-Cycle’ substrates to give 
enantioenriched chiral pyrrolidines.   
Scheme 1: 'Clip-Cycle' asymmetric reaction 
‘Clip-Cycle’ involves an unsaturated Cbz-protected ‘allyl’ amine being ‘clipped’ with an activating 
unsaturated thioester group by an alkene metathesis reaction, followed by a chiral phosphoric 
acid (CPA) catalyzed aza-Michael ‘cycle’ reaction. Racemic 2-, and 3-substituted cyclisation 
precursors were cyclized using (R)-TRIP and the conversion monitored until 50% of the substrate 
had been consumed. Analysis of the reaction mixture by chiral HPLC indicated that kinetic 
resolution had occurred in all cases studies with up to 90% ee and s=122. 
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8.1 Pyrrolidines in Natural Products  
 
The most predominant heterocycles in medicinal chemistry and natural/pharmaceutical products 
are nitrogen-based heterocycles, five- and six-membered systems, such as pyrrolidine and 
piperidine. Also prominent are structures containing two heteroatoms within the carbocyclic ring, 
such as morpholines, and piperazines (Figure 1). 
 
Figure 1: Common N-heterocycles 
Nitrogen-containing heterocyclic structures are increasingly desirable scaffolds for drug discovery 
as they are present in many drug molecules and biologically active natural products. A recent 
report demonstrated that 59% of FDA approved drug molecules are cyclic amines; piperidines are 
in the 1st place while pyrrolidines are the 5th most frequent approved drugs.1 
The pyrrolidine ring has become a privileged structure in medicinal chemistry. The great interest 
in this heterocycle is based on the fact that that pyrrolidines form the central structure of the 
amino acid proline, and are present in plenty of natural products and alkaloids2,3  (Figure 2). 
 
 




Additionally, many substituted pyrrolidine derivatives are acknowledged to possess a wide range 
of bioactivities, such as antibiotic, antibacterial, antifungal and cytotoxic effects, and 
consequently offer an excellent opportunity for the discovery of new pharmaceuticals agents4,5,6 
(Figure 3).  
  
 
Figure 3: Structures of pyrrolidine moieties in pharmaceutical drugs 
 
Enantiopure polyfunctionalized pyrrolidines are also found in pharmaceuticals and in numerous 
natural products; they are useful chiral auxiliaries and ligands for asymmetric syntheses, too. 
Although many methods have been reported for the synthesis of pyrrolidines, the continuing 
challenge is to design more concise methods, particularly enantiopure examples that have ring 
functionality that can provide access to more complex derivatives. 
 
8.2 Asymmetric Synthesis of Chiral Pyrrolidines 
 
In recent years, several reports for the asymmetric formation of pyrrolidine rings have appeared 
in the literature.  A selection of these methodologies is presented below to demonstrate the 
scope of enantioselective synthesis of these N-heterocycles in as a powerful tool in organic 
chemistry.  
 
One successful method in asymmetric synthesis is using asymmetric deprotonation to form N-Boc 
pyrrolidines via a chiral ligand like (-)-sparteine 21 to induce stereochemistry. An example from 
Beak’s7 work is illustrated: an asymmetric deprotonation-cyclisation of the N-Boc amino chloride 
19 using (-)-sparteine and sec-butyllithium (s-Buli) to yield (S)-pyrrolidine 20 in toluene (96% ee). 
These enantioselective lithiation-cyclizations were applied to a range of substrates with good to 





Scheme 3: Sparteine mediated asymmetric deprotonation/cyclisation to form N-Boc pyrrolidines 
 
The key step of the reaction in the enantioselective induction is enantioselective deprotonation 
by s-BuLi/ (-)-sparteine complex to yield an enantioenriched lithiated species which undergoes 
cyclization more rapidly than racemization. Mechanistic studies, also, shows that the 
enantioselectivity is introduced by the asymmetric deprotonation at the benzylic position by the 
s-BuLi/ chiral ligand complex  (Scheme 4). 
 
Scheme 4: Pathway of the asymmetric deprotonation-Cyclization of 19 to (S)-20 
 
Carbone et. al. investigated a series of asymmetric deprotonations of N-Boc-pyrrolidine followed 
by functionalisations  using s-BuLi or i-PrLi and (-)-sparteine- or (+)-sparteine surrogate that 
yielded pyrrolidine rings with high enantioselectivity.  Lithiation of N-Boc-pyrrolidine 22 with s-
BuLi/ (-)-sparteine 21 or (+)-sparteine surrogate 24 affects an asymmetric deprotonation which 
yields the anion which reacts with electrophiles to provide the 2-substituted N-Boc-pyrrolidines 
23a, 23b and in enantiomeric ratios which generally are >90%. 8,9 Below are shown two 
representative examples of asymmetric deprotonation reactions that were investigated; different 
solvents and R-Li reagents were tested (Scheme 5, Scheme 6).  
 
 
Scheme 5: Asymmetric Lithiation of N-Boc Pyrrolidine using (-)-sparteine 
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It was found that reactions with (-)-sparteine in tetrahydrofuran and 2-methyl-tetrahydrofuran 
proceeded with low enantioselectivity and yields for both syn and anti products (Table 1, Entries 
4-6). Upon use with diethyl ether or methyl tert-butyl ether yielded in increased 
enantioselectivities; moderate yields were obtained in all cases (Table 1, Entries 1-3).   
 
Entry Solvent R-Li Yield of syn %ee of syn Yield of anti %ee of anti 
1 Et2O i-BuLi 64 97:3 22 95:5 
2 Et2O s-BuLi 63 97:3 23 97:3 
3 TBME s-BuLi 51 97:3 24 98:2 
4 THF i-BuLi 65 63:37 22 60:40 
5 THF s-BuLi 50 51:49 14 51:49 
6 2-methyl-THF s-BuLi 50 59:41 29 55:45 
Table 1: Different set of reaction conditions used in asymmetric deprotonation 
 
Conversely the corresponding reactions with the (+)-sparteine surrogate occurred with high 
enantioselectivity in all cases (Table 2, Entries 1-6). However, the yields remained moderate in 
every different set of conditions. 
 
 
Scheme 6:  Asymmetric Lithiation of N-Boc Pyrrolidine using (+)-sparteine surrogate 
 
Entry Solvent RLi Yield of syn %ee of syn Yield of anti %ee of anti 
1 Et2O i-BuLi 68 98:2 23 95:5 
2 Et2O s-BuLi 58 95:5 23 94:6 
3 TBME s-BuLi 56 94:6 31 93:7 
4 THF i-BuLi 66 97:3 21 97:3 
5 THF s-BuLi 45 95:5 20 95:5 
6 2-methyl-THF s-BuLi 43 93:7 22 93:7 
Table 2: Different set of reaction conditions used in asymmetric deprotonations 
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The catalytic asymmetric 1,3-dipolar cycloaddition reaction is conceptually an efficient strategy 
for the enantioselective construction of five-membered heterocycles.  Of particular interest is the 
reaction between azomethine ylides and activated alkenes to form functionalised pyrrolidines.10 
Copper(I) complexes together with a silver-based catalyst,  are the most widely employed 
catalysts in asymmetric 1,3-dipolar cycloadditions of azomethine ylides. Two representative 
examples of the cycloadditions using Copper (I) and silver catalysts are shown below.  
Nájera et. al. reported an exo-selective 1,3-dipolar cycloaddition between iminoesters 25 and 
nitroalkenes 26, using silver triflate or silver benzoate phosphoramidite complexes.11 
Computational work (DFT calculations) suggested that the triflate anion remained coordinated to 
the silver atom along the reaction pathway avoiding the stabilizing endo interaction between the 
metal and the nitro group of the dipolarophile (Scheme 7).  
 
Scheme 7: Ag/phosphoramidite catalyzed exo selective asymmetric 1,3-dipolar cycloaddition of 
azomethine ylides with nitroalkenes 
 
The scope of the reaction was investigated with different nitroalkenes, α-amino esters and 
benzylideneimino esters (Scheme and Table). Parallel studies were carried out for the reaction 
catalyzed by ligand 28 and AgOTf or AgOBz and 19 different substrates were tested. A few 
representative examples are shown in the table below (Table 3). The variation of the aryl 
substituent of the dipolarophile induced higher chemical yields, exo-diastereoselectivties and 
enantioselections in products 18 (Table 3, entries 1-3, 5 and 6). When an alanine derived imino 
ester was employed as azomethine ylide precursor, an increment of the endo-diastereoisomer 
was observed with moderate yield and %ee (Table 3, Entry 4). A tolyl- substituent was obtained in 
an ee up to 82% with moderate exo-selectivity and low yield (Table 3, Entry 5). Finally, in the case 
19 
 
of the 2-naphthyl substituent, exo-product was obtained with up to 85% ee and 70% yield (Table 







Table 3: Scope of the enantioselective 1, 3-dipolar cycloaddition between imino esters and 
nitroalkenes 
 
Cabrera, Gómez and Carretero demonstrated an interesting enantioselective 1, 3-dipolar 
cycloaddition of azomethine ylides catalysed by a copper(I)-Fesulphos catalyst system.12  (Scheme 
8) The catalyst system behaves as an efficient chiral Lewis acid on the catalytic cycloaddition 
reaction and shows a good reactivity at low catalyst loadings (3 mol%) affording endo/exo 
selectivity and high enantioselectivity (>99% ee). This catalytic asymmetric procedure has a broad 
structural scope with regard to both azomethine and dipolarophile substitution.  
 
Scheme 8:  1, 3-dipolar cycloaddition of azomethine ylides 
This protocol provided high levels of diastereoselectivity and enantioselectivity with a wide 
variety of imino esters and dipolarophiles and a few of them are presented below. (Scheme 9)  
The endo/exo selectivity proved to be dependent on the dipolarophile.  The endo-fumarate 
adduct 31a was yielded in excellent %ee and diastereoselectivity, whereas the endo-maleate 31b 
and endo-acrylate 31c products gave lower diastereoselectivity and %ee (endo/exo: 90/10, 67/33 
and 75/25, respectively).  
Entry Ar R1 R2 exo/endo %yield %ee 
1 Ph H Ph 90:10 80 96 
2 Ph H 4-MeC6H4 70:30 52 89 
3 Ph H 4-FC6H4 89:11 74 97 
4 Ph Me Ph 21:79 14 87 
5 2-MeC6H4 H Ph 56:44 33 82 




Scheme 9: Representative examples of Fe-catalyzed 1,3-dipolar cycloadditions of azomethine 
ylides 
 
A simple, yet efficient procedure for the asymmetric synthesis of 2-substituted pyrrolidines with 
high enantiomeric purity has been investigated by Burgess and Meyers in 199113 (Scheme 10).  
 
Scheme 10: Formation of pyrrolidines from keto acid and (R)-phenylglycinol 
Starting from 3-acylpropionic acids "...34, using (R)-phenylglycinol 33, as a chiral auxiliary, 
yielded..."yielded the bicyclic lactam 35. Reacting the intermediate 36 under Lewis acid 
conditions, followed by hydrogenolysis conditions provided the desired N-substituted pyrrolidines 
38. In this transformation, the alane which was prepared in situ from aluminum trichloride and 
lithium aluminum hydride, acts as the necessary Lewis acid to from the intermediate 36 and as a 
hydride source to yield the37. The alane, weakens the C-O bond in 36a promoting N-acyliminium 
ion formation to 36b. Subsequent delivery of the hydride from the same face as the departing 
oxygen then provides the observed pyrrolidine products (Scheme 11). The enantiomeric purity of 
these compounds was determined to be >98% by chiral stationary-phase HPLC. This method was 




Scheme 11: Proposed mechanism of the alane reduction to afford the pyrrolidines 
In the table below, three different substrates’ results are presented (Table 4).  In the case of the 
2-phenyl derivative (Entry 1), an alternative procedure for benzyl-N bond cleavage was devised. 
Diphenyl disulfide and triethylphosphine converted the primary alcohol 37a to the corresponding 
phenyl sulfide followed by treatment with lithium di-tert-butyl biphenylide which resulted in 
lithiation and elimination of styrene to yield the 2-phenylpyrrolidine 38a in 51% yield over the two 
steps (Scheme 12). 
 
Scheme 12: Alternative procedure for 2-phenylpyrrolidine 
The synthesis of the other two pyrrolidine substrates (Entries 2, 3) proceeded smoothly under the 
revised conditions. The assignment of the absolute configuration of the pyrrolidines was based on 
comparison of the observed optical rotation with those from literature and the designation of R or 
S was made.  
Entry R %yield Configuration %ee 
1 Phenyl 51 S  
>98 2 n-propyl 78 R 
3 Cyclopentyl 65 S 
Table 4: Formation of pyrrolidines 38 from keto acid 34 and (R)-phenylglycinol 33 
 
Yu et. al. developed a method for the enantioselective synthesis of various pyrrolidine rings via a 
gold-catalysed tandem cycloisomeriasation/hydrogenation of chiral homopropargyl 
sulfonamides14 (Scheme 13). Chiral pyrrolidines were obtained in excellent yields and 
enantioselectivities by successfully combining gold catalysis with a chiral tert-butylsulfinimine. 
Optimization of reaction conditions led to employing Et3PAuNTf2 as the gold catalyst, triisopropyl 
silane as the organosilane and acetic acid as the additive. The starting homopropargyl 
sulfonamides 39 underwent a direct 5-endo-dig anti-Markovnikov cyclisation / hydrogenation to 




Scheme 13: Gold catalyzed tandem cycloisomerization/hydrogenation of chiral homopropargyl 
sulfonamides 
Consequently, a possible reaction mechanism to explain the formation of 40 was proposed 
(Scheme 14). Initially, the gold catalyst catalyzed the 5-endo-dig cycloisomerization followed by 
the in situ generation of the intermediate 41, which was then converted to the iminium 
intermediate b catalyzed by gold and acid. The iminium intermediate was then reduced by 
hydride to afford the pyrrolidine 40.  
Scheme 14: Proposed reaction mechanism to rationalize the formation of 40 
The scope of this gold-catalysed cycloisomerization/hydrogenation reaction was examined and 16 
different substrates were tested, a few of them presented in the scheme below (Scheme 15).       
In particular excellent enantioselectivities and yields were achieved in almost all cases and no 
epimerization of the precursors was observed. Besides the tosyl group, the reaction proceeded 
well for p-bromobenzenesulfonyl-protected (Bs) substrate 40e, resulting in the efficient formation 
of the desired product.  
 
Scheme 15: Reaction scope representative examples 
 
In early 2019, Krische et. al. demonstrated a successive nucleophilic and electrophilic allylation for 
the catalytic enantioselective synthesis of N-protected 2,4-disubstituted pyrrolidines15 (Scheme 
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16). The allylation, mediated by the bis-Boc-carbonate 42 derived from 2-methylene-1, 3-propane 
diol enables the formation of enantiomerically enriched 2,4-disubstituted pyrrolidines 43. The 
enantioselective iridium-catalyzed transfer hydrogenative carbonyl C-allylation is followed by 
Tsuji−Trost N-allylation using 2-nitrobenzenesulfonamide; a Mitsunobu cyclization provides the N-
protected 2, 4-disubstituted pyrrolidines.  
 
Scheme 16: Enantioselective pyrrolidine synthesis via successive nucleophilic and electrophilic 
allylation 
Initially a variety of alcohols 41 were coupled with bis-Boc-carbonate 42 via alcohol mediated 
hydrogen transfer to form the corresponding adducts 44 (Scheme 17). Selected optimization 
experiments led to using the (S)-Ir(III) catalyst with 5 mol% loading. The conversion of starting 
alcohols to adducts represents redox-neutral processes.  
 
Scheme 17: Redox-Neutral coupling of alcohols with bis-Boc-carbonate to form adducts 44 
The optimized conditions were applied to a range of alcohols 41 which were coupled with bis-Boc-
carbonate 42 and a few representative examples are shown below (Scheme 18). The benzylic 
alcohols delivered the respective adducts 44a, 44b with moderate yields but excellent 
enantioselectivity. The 44c, 44d adducts were generated with moderate yields and high %ee’s 
from the respective aliphatic alcohols.  The absolute stereochemistry of adducts was assigned in 




Scheme 18: Representative examples of corresponding adducts 44a-d 
 
Subsequently, adducts 44a-d were converted to the 2-substituted 4-methylenepyrrolidines 43 via 
a Tsuji – Trost palladium-catalyzed allylation followed by a Mitsunobu cyclisation (Scheme 19).  
 
Scheme 19: Tsuji-Trost allylation reaction followed by Mitsunobu cyclisation 
The palladium-catalyzed allylation reactions of o-nitrobenzenesulfonamide proceeded well, 
providing in good yields the o-nosyl adducts. The following cyclisations under Mitsonobu 
conditions generated the 2-substituted 4-methylenepyrrolidines 43a-d with no erosion in 
enantiomeric purity. In the scheme below, representative examples of the corresponding 
pyrrolidine rings are shown (Scheme 20). 
 
 
Scheme 20 : Representative examples of the corresponding pyrrolidine rings 
 
A common method to synthetize cyclic products from acyclic diene or enyne precursors is via a 
ring-closing metathesis reaction catalyzed by highly active ruthenium catalysts such as first-
generation Grubbs catalyst 47a and second-generation Grubbs catalyst 47b.16  Yang et. al. 
synthesized  a series of pyrrolidine derivatives prepared in good yields via a ring-closing enyne 




Scheme 21: Ring-closing metathesis reaction 
Initially, several enyne substrates were generated from commercially available chiral amino acids, 
based on literature procedures. A variety of chiral pyrrolidine derivatives were prepared from the 
enyne substrates containing a basic or nucleophilic N atom via ring-closing enyne metathesis 
reaction under mild reaction conditions and a few of them are presented in the scheme below 
(Scheme 22).  
 
Scheme 22: Representative examples of the ring-closing metathesis reaction 
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Enynes containing aromatic rings or alkane chains afforded the corresponding pyrrolidines in good 
yields.(46a-e). To further expand the scope, substrates with substituents on the alkene bond were 
tested 46f. When 46f was subjected to the reaction conditions, starting material was recovered 
due to the steric effect, resulting in low yield (31%). Additionally, the 46e substrate which 
contains a sulfur atom gave no reaction under the conditions, but when 40 mol % of Ti(OiPr)4 was 
added to the reaction the pyrrolidine was generated successfully in 68% yield. This may be due to 
the fact that the sulfur atom is a stronger electron donor, therefore causing the alkylidene 
ruthenium carbene to coordinate with the sulfur atom and deactivation of the catalyst.  
 
An enantioselective synthesis of 2-substituted pyrrolidines via an intramolecular reductive 
amination was reported by Chang et. al.18 (Scheme 23). This concise, one-pot synthesis is 
catalyzed by an iridium/chiral ferocene ligand to yield the 2-aryl pyrrolidines in excellent 
enantioselectivities. The starting carbamates 48 were subjected to N-deprotection under 
trifluroacetic acid conditions and cyclized to form 2-substituted aryl pyrrolidines 49, in which the 
intramolecular reductive amination was the key step. The use of the three additives Ti(OiPr)4, Et3N 
and KI enchanced the conversion and the strereoselectivity of the reaction. A range of chiral 
pyrrolidines were synthetised up to 98% yield and 92% ee.  
 
Scheme 23: Enantioselective synthesis of 2-substituted pyrrolidines via intramolecular reductive 
amination 
A few representative examples are shown in the scheme below (Scheme 24). For the para-
substituted substrate 49b, the steric properties or their electronic effect of the substituent had 
almost no effect on the reaction enantioselectivity or reactivity and excellent yield and %ee were 
obtained. Similarly, the subtituent on the meta-position 49c converted smoothly into the 
corresponding pyrrolidine with no difference in reactivity and enantioselectivity. However, the 
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ortho-substituted substrate 49d was generated in a decreased yield and %ee, which might be 
from the steric hindrance of the position. The catalytic system did not work well for the 
piperidine-substituted product 49e and only 32% was achieved.  
 
 
Scheme 24: Representative examples of scope of the reaction 
 
 
8.3 Asymmetric aza-Michael reactions for the synthesis of N-heterocycles 
 
The aza-Michael reaction; the 1,4-addition of a nitrogen nucleophile to an α,β-unsaturated 
carbonyl compound, is an excellent and useful way of forming C-N bonds and is of great 
significance in asymmetric synthesis. Indeed, the reaction in its intramolecular version constitutes 
a quite straightforward methodology to construct nitrogen-containing heterocycles.19 
 
Fustero et. al. reported general procedures for highly enantioselective organocatalysed 
intramolecular aza-Michael reaction to access different nitrogen containing ring sizes, such as 
pyrrolidines and piperidines.20 In a recent report they demonstrated an example of asymmetric 
intramolecular aza-Michael reactions of carbamates bearing α, β-unsaturated ketones as Michael 
acceptors21 (Scheme 25). The carbamate 51 undergoes a cross metathesis reaction using 
Hoveyda-Grubbs 2nd generation catalyst to form the enone 52. The organocatalyst 54 combined 
with pentafluoropropionic acid as co-catalyst drive the stereoselective aza-Michael attack. The 




Scheme 25: A microwave-assisted organocatalytic enantioselective intramolecular aza-Michael 
reaction 
A plausible mechanism reaction was suggested and described the iminium intermediate 55 which 
can be seen in the figure below: a hydrogen bond is formed between the carbamate carbonyl 
oxygen group and the acidic proton from the quinuclidinium group of the catalyst and that could 
drive a stereoselective aza-Michael attack. The conjugate addition of the nucleophilic nitrogen 
would happen on the Re face of the less sterically hindered iminium to generate the Michael 
product in R-configuration (Figure 4). 
 
 
Figure 4: A model of the transition state  
Fustero22 and Carter23, demonstrated the transformation of carbamates bearing α, β-unsaturated 
aldehydes into the enantiomericaly enriched nitrogen heterocycles via an organocatalysed 
intramolecular aza-Michael reaction (Scheme 26). The conjugate aldehyde 57 with Jorgensen 
diarylpropinol catalyst 61 and benzoic acid as co-catalyst yielded the piperidine 58 in excellent 
enantioselectivity. The piperidine 58 was further exploited for the synthesis of the piperidine 
alkaloids, (+)-myrtine 60.  
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Scheme 26: The total synthesis of (+)-myrtine 
 
The aza-Michal reaction takes place via an iminium intermediate that favors the attack of the 
nucleophilic nitrogen onto the less hindered Re-face of activated olefin 63, as shown in the figure 
below. (Figure 5)   
 
 
Figure 5: Iminium intermediate 
 
In 2014, Azuma et.al. demonstrated an asymmetric intramolecular heteroMichael reaction of α,β-
unsaturated carboxylic acids24 (Scheme 27). A combination of an aryl boronic acid 68 with a chiral 
aminothiouria 69 catalyzed the intromolecular oxa- and aza-Michael reactions to yield the desired 
heterocycles 65,67 in high yields and enantioselectivities. Upon screening different catalysts and 
conditions, they established that the yields and the enantioselectivities could be improved with a 
dual catalytic system of boronic acid 68 and thiourea 69. Solvent screening led to using a mixed 
solvent system of methyl tert-butyl ether (MTBE) and carbon tetrachloride (CCl4). The reaction 
worked well for oxy-Michael reaction as the benzofuran and chromane derivatives 65 were 
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obtained in high yields and enantioselectivies; whereas the formation of the N-tosyl pyrrolidine 67 
afforded poor %ee’s and yields. The reaction also uses CCl4, a solvent not widely used due to its 
carcinogenicity and environmental concerns. 
 
Scheme 27: Asymmetric oxa-Michael and aza-Michael addition catalyzed by aryl boronic acid 68 
and thiourea 69 
Carlson et. al. reported a procedure for enantioselective intramolecular hetero atom Michael 
addition via organocatalysis25 (Scheme 28). 
 
Scheme 28: Asymmetric hetero atom Michael reaction via organocatalysis 
The organocatalyst, a diaryl TMS-proline derivative facilitated the asymmetric synthesis of 
pyrrolidines, indolines and piperidines 71 with good yields (60-70%) and enantioselectivities (79-
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95%). The method was further extended to the enantioselective synthesis of homoproline 72, 
homopipecolic acid 73 and pelletierine 74. The proposed mechanism for the reaction is shown in 
the figure below (Figure 6).  The catalyst is a Jørgensen’s trifluoromethyl derivative, forms a chiral 
α, β-unsaturated iminium species 75 to activate the Michael acceptor and utilises sterically 
demanding groups to force attack from one side of the molecule.  
 
Figure 6: Key step from the proposed reaction mechanism   
The reaction scope was extended and a few examples are presented below (Scheme 29). It was 
found that dimethyl substitution in the second position on the ring led to reduced reactivity, due 
to steric effects. The 2-dimethyl pyrrolidine 71a required an extended reaction time to proceed to 
completion (4 days) and led to reduced enantioselectivity whereas the synthesis of 2-dimethyl 
piperidine 71d was not successful even under extended reaction times and increased catalyst 
loading. Dimethyl substitution on the third position 71b, 71c yielded increased reactivity and good 
levels of enantiomeric excess. 
 
Scheme 29: Representative examples of the asymmetric hetero atom Michael reaction  scope 
In 2010, Farwick and Helmchen introduced a stereoselective synthetic methodology of β-proline 
derivatives from allylamines26 (Scheme 30). The route proceeds via a domino 
hydroformylation/Wittig olefination, followed by a separate intramolecular aza-Michael addition.   
 
Scheme 30: Synthetic methodology of β-proline derivatives 
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The intramolecular aza-Michael reaction proceeds with high trans-diastereoelectivity if 2, 5-
substituted pyrrolidines are formed; the cyclisation of urethanes PG1: Boc/Cbz proceeds to give a 
product containing a trans-configuration  at a reaction temperature of -78 oC and use of 
potassium tert-butoxide (t-BuOK) as a base.  
 
The domino hydroformylation/Wittig olefination under optimized reaction conditions afforded 
the N, N-diacylamines 77 in excellent yield (72-95% yield) with E/Z selectivity (Scheme 31). 
 
Scheme 31: Domino hydroformylation/Wittig olefination reaction 
  
The rhodium-catalyzed hydroformylation reaction was catalyzed by the ligand Biphesphos 80 in a 
ration 5:1 (ligand: Rh) to ensure stereoselectivity. Short reaction times reaction times (5-13 h) and 
low temperatures with a combination of synthesis gas (H2/CO 1:1) led to full conversion of the 
starting allylamine derivatives. Those set of conditions were used to expand the scope of the 
domino reaction with a variety of allylamine derivatives and representatives stabilized Wittig 
ylides. Three representative examples of the Domino reaction are presented in the scheme below 
(Scheme 32).  E/Z selectivity was typical for the Wittig olefination. The aromatic substituent 77a 
was afforded in excellent yield as well as the alkane chain 77b and the tert-butyldiphenylsilyl 77c 
ones.  
 
Scheme 32: Representative examples of domino hydroformylation/Wittig olefination reaction 
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The N,N-diacylamines  77 were converted to the mono-protected amides which were used as the 
starting materials for the aza-Michael reaction (Scheme 33). 
 
Scheme 33: Selective deprotonation and intramolecular aza-Michael reaction 
 
The selective deprotection  of the formyl or Boc group was affected with KOH (cat.)/methanol or 
with TFA/ CH2Cl2 respectively. The aza-Michael reactions were effected with KO-t-Bu (0.8 equiv.) 
as base at a reaction temperature of -78 oC in THF as solvent at a reaction time of 20 min. The 
trans-diastereoisomers 80 were generated in good to excellent yields (68–97%). No cis-isomers 
were detected by 1H NMR under the reaction conditions. The enantiomeric excess was 
determined for a few of the 2,5-disubstituted pyrrolidines and it was found to be equal to that of 
the starting chiral allylamine derivatives. Thus, no racemization had occurred in the 
hydroformylation reaction. The corresponding results are shown in the table below (Table 5). The 
2-phenyl substituted pyrrolidine derivative (Entry 1) was obtained in good yield and %ee whereas 
as the n-heptane and tert-butyldiphenylsilyl groups (Entries 2, 3) were afforded in excellent 
enantiomeric excess and yield.  




Nagorny et. al. published an enantioselective synthesis of piperidines catalyzed by chiral 
phosphoric acids27 (Scheme 34). This report was the first example of the asymmetric cyclisation of 
unsaturated acetals 82 leading to functionalized piperidines 83 with good enantioselectivities (56-
99%). Optimization of the cyclisation reaction conditions lead to carbon tetrachloride as the 
solvent, the chiral phosphoric acid 84 at -20 oC, as lower reaction temperatures improved 
selectivity. Computational work revealed that the mechanism involves the formation of a mixed 




% ee of C 
1 Ph Boc CHO a 93 80 96 
2 n-hept Boc Boc b 81 97 97 
3 CH2OSi(t-Bu)Ph2 Boc CHO a 71 91 94 
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chiral phosphate acetal which undergoes a concerted asynchronous SN2’-like displacement 
yielding  the products. Additionally, the axial chirality of the BINOL-based catalyst 84 controls the 
direction of the Michael addition, leading to high enantioselectivity. 
 
 
Scheme 34: Enantioselective synthesis of piperidines catalyzed by chiral phosphoric acids 
The methodology was applied to the synthesis of a number of substituted piperidines, specifically 
gem-dimethyl, fused phenyl, cyclopentyl and more examples. A few representative examples are 
shown in the scheme below (Scheme 35). Most examples gave good yields and good ee’s 
although the 6,6’-dimethyl compound 83c was an exception with 54% yield and 56% ee after 72 h. 
Substituents of the fourth and fifth position 83a, 83b, 83c had a beneficial effect on the selectivity 
of the reaction and highly enantioselective products were formed. The reaction was also 
performed in CCl4 which raises health concerns.  
Scheme 35: Representative examples of the enantioselective synthesis of piperidines catalyzed by 




8.4 Kinetic Resolutions 
8.4.1. Concept of Kinetic Resolutions 
 
Kinetic resolution is often a valuable alternative for preparing important chiral compounds and 
can offer many advantages.28 In kinetic resolutions a chiral catalyst or chiral reagent is employed 
to react with an enantiomeric mixture that is difficult to separate. Ideally, only one enantiomer 
reacts towards the product. Due to the resulting different physical properties of the two products 
they can be separated easily with common methods (Scheme 36). 
 
 
Scheme 36: A classical kinetic resolution 
The success of this method depends on the fact that the two enantiomers react at different rates 
with a chiral catalyst, so one of the two transition states is lower in energy than the other one.  
 
Kinetic resolution occurs when the reaction rate of one enantiomer differs from the reaction rate 
of the other enantiomer (kR ≠ kS) and the reaction is stopped at 50% conversion. Ideally, one 
enantiomer reacts much faster than the other; for example, if the starting reactant substrate with 
the absolute configuration R is the only reacting enantiomer (kS = 0). In this case, 50% conversion 
of the initial 50/50 mixture leads to a final mixture of 50% reactant (S) and 50% product (P). The 
quality of the kinetic resolution is typically expressed with the selectivity (s-factor). The s-factor is 
a measurement for the effectiveness of a kinetic resolution and relates the rates of the reaction of 
the two enantiomers with the chiral reagent. It is calculated by the fraction of the rate constant 
for one enantiomer kR by the rate constant for the other enantiomer kS (Figure 7). 
 
Figure 7: Different transition state energies in kinetic resolution 
While both enantiomers are at the same Gibbs free energy level by definition, and the products of 
the reaction with both enantiomers are also at equal levels, the transition state energy (ΔGǂ) can 
differ. As shown in the figure above, the transition state for the R enantiomer has a lower ΔGǂ and 
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would react faster than the S enantiomer. In the ideal kinetic resolution only one enantiomer 
reacts, i.e. kR>>kS. The selectivity (s-factor) of a kinetic resolution is related to the rate 
constants of the reaction of the R and S enantiomers, kR and kS respectively, by s=kR/kS, for kR>kS 
In kinetic resolutions any enantiomeric ratio can be obtained by sacrificing yield and therefore by 
controlling the conversion. The enantiomeric ratios of the product and the recovered starting 
materials after the resolution are dependent on both the s-factor and the conversion. In an 
optimal kinetic resolution (high s-factors) enantiopure products can be obtained at 50% 
conversion. This represents the maximum possible yield in classical kinetic resolutions. Generally, 
any kinetic resolution with a reasonable selectivity (>20) can deliver 99% ee with in useful yields. 
Provided that selectivity factors greater than 20 can be obtained, kinetic resolution can be used to 
separate enantiomers with acceptable yield and outstanding enantiopurity. Despite the 50% 
maximum yield, kinetic resolutions can be a reliable, effective, and easily implemented method 
for the production of enantiopure material.29 
 
8.4.2 Examples of Kinetic Resolutions 
 
Jacobsen et. al. developed a kinetic resolution of the hydrolytic opening of epoxides via 
nucleophilic ring opening with attack by water and a cobalt complex as catalyst30 (Scheme 37). 
 
Scheme 37: Jacobsen’s hydrolytic kinetic resolution 
This procedure uses water as the only reagent, no added solvent and low loadings of the chiral 
catalyst and it affords terminal epoxides and 1, 2-diols in high enantiomeric excess (>95% in nearly 
all cases) and quantitative yield. The nucleophile effectively opens the epoxide at the terminal 
position enantioselectively, providing access to both unreacted epoxide and 1,2-diol products. 
The hydrolytic kinetic resolution was applicable to a series of terminal epoxides and 
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representative examples are shown in the table below (Table 6). The alkyl-substituted epoxide 
underwent efficient resolution with high %ee’s for both the diol and the unreacted epoxide and 
an excellent relative rate constant (Entry 1). The aromatic and the conjugated epoxides were 
resolved with lower selectivities but highly enantiomerically enriched epoxide and diol were 
obtained (Entries 2, 3). 
Concentration                                Epoxide                Diol 




Time (h) %ee %yield %ee %yield krel 
1 CH3 0.2 0.55 12 >98 44 98 50 >400 
2 Ph 0.8 0.7 44 98 38 98 39 20 
3 CH=CH2 0.64 0.50 20 84 44 94 49 20 
Table 6: Representative examples of Jacobsen’s hydrolytic kinetic resolution 
 
 
In early 2000s, Fu and co-workers published a catalytic enantioselective acylation focused on  
application of a planar-chiral DMAP derivative to the kinetic resolution of allylic alcohols31 
(Scheme 38).  
 
Scheme 38: Kinetic resolution of allylic alcohols by a non-enzymatic acylation catalyst 
The catalyst can affect the kinetic resolution of most allylic alcohols with good selectivity. This 
enantioselective acylation was applied to a variety of substrates with high enantioselectivity and 
good selectivity for most substrates (90-99% ee). A few representative examples of the recovered 




Scheme 39: Unreacted alcohols-major enantiomer of the kinetic resolution of allylic alcohols by a 
non-enzymatic acylation catalyst 
The allylic alcohol 88a does not have a subsitutent geminal or cis to the hydroxyl group and was 
resolved with low selectivity but high enantiomeric excess. However, the phenyl group in the 
trans position 88b increased the selectivity factor as well as the %ee. Kinetic resolutions of allylic 
alcohols that are substituted geminal 88c or cis 88d to the hydroxyl group proceeded with 
moderate selectivity; the phenyl-group improved the selectivity factor.  
 
 
Bode et.al. 32 published a method for the catalytic kinetic resolution of cyclic secondary amines 
(Scheme 40). The methodology employs two catalysts working synergistically to generate 
enantiopure cyclic amines. 
 
Scheme 40: Catalytic kinetic resolution of cyclic secondary amines 
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The key advance was the use of a chiral hydroxamic acid 93 and an imidazole 94 co-catalyst as 
highly enantioselective acylating agent. The starting racemic amines 12 were treated with α’-
hydroxyenone 92 (acylating agent) the chiral catalyst 93, the imidazole co-catalyst 94 and 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) in dichlormethane (CH2Cl2) at 23 
oC for 18h and produced 
enantiomerically enriched amides 95. These set of conditions were applied for a range of 
substituted piperidines, piperazines, morpholines, and tetrahydroisoquinolines. The 
enantiomerically enriched amines 91 and amides 95 were generated with high selectivity factors 
(s up to 127). Substituted piperazines and morpholines, both of which are were resolved with s 
factors ranging from 11 to 23. Tetrahydroisoquinolines were resolved with excellent levels of 
selectivity (up to s = 74).  
A few of different substrates tested are presented in the table below (Table 7).  The 2-benzyl 91a 
and the 2-phenyl 91b piperidines were resolved with good s-factors and high enantioselectivities 
for the amides, while the %ee for the recovered amines were moderate (70%). Similarly, the 
morpholine 91c was resolved with good s-factor and enantiomeric excess whereas the 
tetrahydroquinoline 91d substrate was generated with excellent %ee and higher s-factor than the 
rest of the substrates mentioned.  








34 (34) 70:70 94:6 23 
 
41 (41) 70:30 92:8 21 
 
40 (40) 79:2 93:7 24 
 
56 (47) 93:7 95:5 53 
Table 7: Representative examples of the catalytic kinetic resolution of cyclic secondary amines 
 
 
A publication by Buchwald et. al. demonstrates a highly enantioselective kinetic resolution of 
disubstituted pyrrolidines via an asymmetric hydrogenation reduction catalyzed by a chiral 




Scheme 41: Kinetic resolution of disubstituted 1-pyrrolidines catalyzed by a chiral titanocene 
catalyst 
The active titanocene catalyst 96 is generated in situ and the hydrogenation proceeds in 
tetrahydrofuran at 65-75 oC with 80 psig of H2 until the reaction which was monitored by 
1H NMR 
reached at 50% conversion. This kinetic resolution of 2, 5-disubstituted pyrrolidines 97 was 
extended to a variety substitution pattern of aromatic groups with high levels of enantiomeric 
excess.  A few of them are shown in the table below (Table 8). 
Substrate %yield (%ee) recovered 97 % yield (%ee) 98 
 
37 (99) 34 (99) 
 
- (75) 42 (>95) 
 
33 (47) 44 (99) 
Table 8: Representative examples of the kinetic resolution of disubstituted 1-pyrrolidines 
catalyzed by a chiral titanocene catalyst 
The 2-phenyl 5-alkyl substituted pyrrolidine 97a underwent an effective kinetic resolution with 
high levels of enantioselectivity for both recovered pyrrolidine and the cis-pyrrolidine product. 
The 3-benzyl 2-phenyl pyrrolidine 97b was resolved with modest enantioselectivity for the 
recovered pyrrolidine but with high %ee for the product 97c. The yield of the recovered 
pyrrolidine could not be determined due to racemization on the silica gel column; the %ee was 
determined by high-performance liquid chromatography (HPLC) analysis. The resolution of 2,4-
disubstituted substrate was relatively poor for the recovered pyrrolidine  97c but the product 98c 
was produced in high enantioselectivity. The reduction of 97b, 97c substrates produced 
predominantly cis products. Substrate 97b was reduced with a higher level of diastereoselectivity 
(cis:trans 85:15) than was 97c (cis:trans 75:25).  The active Ti(III) hydride catalyst forms two 
different diastereomeric complexes upon reacting with the starting substrate. Studies on these 
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complexes revealed that substrates with a substituent at C-3 should be more efficiently kinetically 
resolved than those with a C-4 substituent. This prediction is consistent with the results that the 
%ee of the recovered pyrrolidine obtained with substrate 97b is higher than that for recovered 
substrate 97c (Table 8).  
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8.5 Background Work 
 
The Clarke group has developed a stereodivergent oxy-Michael cyclisation for the stereoselective 
synthesis of tetrahydropyrans, which converts an alcohol tethered to an α,β-unsaturated 
thioester into either 2,6-cis or 2,6-trans tetrahydropyrans34 (Scheme 42). 
 
Scheme 42: Stereodivergent oxy-Michael Cyclisation 
The α,β-unsaturated thioester under acetic acid-TBAF conditions produced 2,6-trans-
tetrahydropyran rings  100 up to  20:1 diastereoselectivity, but, under TFA conditions formed the 
2,6-cis configuration 101 up to 13:1 diastereoselectivity. In order to explain these interesting 
results, computational studies were carried out35 (Figure 8). It was then proven, that under TFA 
conditions the TFA acted as a ‘proton shuttle’ and played a dual role as it protonates the thioester 
carbonyl C=O and deprotonates the alcohol OH. The calculations also revealed that the molecule 
adopts a chair-like transition state and the cis-product was favoured, supporting the results seen 
in the synthetic studies. In contrast, the 2,6-trans-configuration was obtained under TBAF 
conditions; the 4-hydroxyl group was involved in stabilization of the transition state and acted as a 
hydrogen-bond donor. The calculations predicted that the absolute stereochemistry of these THPs 
to be (S)-configuration and experimental data were compared with literature and confirmed the 
results. 
 
Figure 8: Transition states under TBAF and TFA cyclisations 
Computational studies (DFT calculations with KE) suggested that the Brønsted acid catalyzed 
reaction could be made asymmetric by the use of a chiral Brønsted acid that acts as a proton 
shuttle. The Brønsted acids TFA (pKa = −0.3) and CSA (pKa = 1.2) act as proton shuttles in the oxy-
Micheal reaction, chiral Brønsted acids with similar pKa values should be able to perform the 
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same function. Subsequent the cyclisation of alcohols 102 to generate (S)-tetrahydropyrans 103 in 
excellent yields and %ee’s 36 (Scheme 43). 
  
Scheme 43: Asymmetric tetrahydropyran cyclisation 
Based on these encouraging results, we decided to extend this approach to the asymmetric 
synthesis of pyrrolidines via an intramolecular aza-Michael reaction.37 A new ‘Clip-Cycle’ 
methodology was developed, which an unsaturated protected ‘allyl’ amine is ‘clipped’ with an 
activating unsaturated thioester group by an alkene metathesis reaction, followed by a ‘cycle’ aza-
Michael reaction, which is catalyzed by a chiral Brønsted acid. The chiral phosphoric acid acts as a 
catalytic proton shuttle, deprotonating the protected amine nitrogen and protonating the 
thioester carbonyl simultaneously which catalyses the reaction. This strategy can be applied to 
the synthesis of any ring size cyclic amines and in other heterocycles, too (Scheme 44). 
 
Scheme 44:‘Clip-Cycle’ Approach and proton shuttle transition state with the chiral phosphoric 
acid 
The reacting groups were chosen through synthetic and computational studies. The Cbz-protected 
amine units have similar nucleophilicity and pKa to alcohols and they are easy to deprotect.  α,β-
unsaturated oxoester, ketones and thioesters were screened to determine which one gives 
optimum %ee’s and yields. It was found that α,β-unsaturated oxoesters are not reactive, lead to 
decomposition of substrate and gave low yields (8% yield and 90% ee), while α,β-unsaturated 
ketones are too reactive as they cyclized during the metathesis reaction forming racemic 
products. However, the α,β-unsaturated thioesters gave excellent results , resulting to 83% yield 
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and 96% ee and it was concluded that they sit in the ‘Goldilocks zone’ of reactivity among the 
Michael acceptors (Scheme 45). 
Scheme 45: Asymmetric synthesis of substituted pyrrolidines using α,β-unsaturated thioesters as 
Michael acceptors and (R)-TRIP as the catalyst 
Computational work was carried out (with KE, B3LYP/6-31G**, solvent SMD(cyclohexane)) and 
suggested that the amines should cyclise onto α,β-unsaturated thioesters to form pyrrolidines 
with high enantioselectivity and indicated formation of (S)-product with (R)-TRIP(Figure 9). 
Computational work suggested that the Brønsted acid acts as a proton shuttle and catalyzes the 
cyclization, which is the stereochemical-determining step. This step can give either the E or Z enol, 
depending on whether the thioester adopts an s-cis or s-trans conformation. It can also have two 
configurations of the newly formed stereocentre, depending on which face the nitrogen attacks. 
As demonstrated in the energy diagram below, the energy of the transition state of the S, E 
cyclized product (90.8 kcal/mol) is lower than the energy of the R, Z configuration (96.1 kcal/mol), 
therefore the catalysed process of the S, E pathway is the most favorable. The steric clash 
between the different positions of the thioester α- proton is the main reason the difference in the 
energies. In the S, E transition state it is pointing away from the catalyst pocket while in the R, Z 
transition state it is pointing inwards allowing the carbamide to approach from the other side. The 
computational study predicted formation of the (S)-product with ~74% ee. Preliminary synthetic 







Figure 9: Computational work on cyclisation selectivity 
The absolute stereochemistry of the cyclisation was confirmed as (S)-configuration by conversion 
of the thioester group 107 to methyl ester 108 and comparison with literature data38 (Scheme 46). 
 
Scheme 46: Methyl ester synthesis 
In the Clarke group, the first project on the ‘Clip-Cycle’ methodology on pyrrolidines involved an 
enantioselective synthesis of spirocyclic and non-spirocyclic pyrrolidines.37 The synthetic 
approaches started with the synthesis of precursors which were subjected to a range of chiral 
phosphoric acid catalysts with solvents, temperatures and reaction times to find optimal 
conditions for the reaction. As a representative example, 2, 2-dimethyl substituted precursor 105 
was used and the various conditions screened are shown below (Scheme 47, Table 9). Screening 
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the conditions started with attempts to find a suitable solvent for the system. Initial reaction tests 
showed that the reaction did not proceed in room temperature, so higher temperatures were 
required. Previous work in the Clarke group suggested that for chiral Brønsted acids low polarity 
solvents gave better results.36 This is due to the fact that high polarity solvents may interrupt the 
ion pairing interaction between the catalyst and substrate. For this reason, cyclohexane (bp. 81 
°C), toluene (bp. 111 °C), and 1, 2-DCE (bp. 84 °C), were tested as the initial solvents with 1, 2-DCE 
being the most polar of the solvents and cyclohexane least polar. For the catalyst screening, the 
Chiral Brønsted acids that were used are (R)-TRIP, (R)-TiPSY, (R)-phen-cat and (R)-anth-cat 
(Scheme 48).  Upon heating the reaction at 50 oC in the four different solvents (Entries 1-3), (R)-
TRIP gave high enantioselectivities (90-93%) but with poor conversion (15-47%). Increased 
temperatures (80 oC) lead to increase in conversion with no drop in the %ee (Entry 5). (R)-anth-cat 
gave excellent conversion and yield with low enantioselectivity (Entry 7), while (R)-TiPSY and (R)-
phen-cat gave lower conversions and %ee’s (Entries 5,6). Through the process of optimisation, 
(R)-TRIP in cyclohexane at 80oC for 24h was chosen as the standard set of conditions. 
 
Scheme 47: Chiral phosphoric acid cyclisation of the 2,2-dimethyl substituted precursor 
 
 Catalyst (20 mol%) Solvent T / °C Conversion% Yield% ee% 
1 (R)-TRIP cyclohexane 50 47 38 91 
2 (R)-TRIP toluene 50 21 18 93 
3 (R)-TRIP 1,2-DCE 50 15 12 90 
4 (R)-TRIP cyclohexane 80 100 77 93 
5 (R)-TiPSY cyclohexane 80 26 22 58 
6 (R)-phen-cat cyclohexane 80 26 21 45 
7 (R)-anth-cat cyclohexane 80 100 99 63 





Scheme 48: Chiral phosphoric acids 
With a set of conditions in hand, the scope was extended to spirocyclic and non-spirocyclic 
substitutions at the 3,3’- and 2,2’- positions of the pyrrolidine ring. Representative examples of 
the cyclisation scope are shown below (Scheme 49). 
 
Scheme 49: Spirocyclic substituted pyrrolidines synthetised 
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8.6 Aim of Project 
 
It was decided to further expand the scope and examine the kinetic resolution of chiral but 
racemic substrates, given the encouraging results of the ‘Clip-Cycle’ methodology for the 
asymmetric synthesis of substituted pyrrolidines (Scheme 50). In our earlier studies achiral 
substrates were used, however in these studies, there is a stereocentre that could influence the 
diastereoselectivity of the cyclisation. Each enantiomer of the starting material 113 could cyclize 
to give either the 2,5-trans-cyclic amine 114a or the 2,5-cis-cyclic amine 114b.  
 
Scheme 50: Enantioselectivity and Diastereoselectivity in our Kinetic Resolution 
In case of achiral Brønsted acid catalyzed cyclisations, literature examples of cyclic amines such as 
piperidines, piperazines and morpholins39  indicate the formation of 2,6-trans- diastoreomer but 
we are not aware of any example regarding the pyrrolidine forming cyclisations.  Our survey of 
the literature indicates that the diastereoselectivity, in pyrrolidine forming cyclisations, is 
dependent upon the type of cyclisation reaction used.40  
The aim of this project was to study the asymmetric synthesis of substituted pyrrolidines using a 
chiral phosphoric acid via a kinetic resolution, which would lead to the formation of 
enantioenriched pyrrolidine products. Upon completion of the kinetic studies, attempts were 
made to determine the diastereoselectivity as well as the enantioselectivity in the kinetic 
resolutions.  Chiral HLPC in conjunction with 1H NMR were used to study the kinetic resolutions, 
which would allow to build up a kinetic profile of the reaction, calculate s-factors and, determine 









9. Results and discussion 
9.1 Retrosynthetic Analysis of the Pyrrolidine Precursors  
The cyclisation precursors were synthesized via two different straightforward synthetic routes 
already developed in the Clarke group from commercially available starting materials. 
Retrosynthetic analysis of the cyclisation precursors simplifies them to the thioacrylate 118 and 
the corresponding Cbz-protected amines 113a-c, which can then be joined through a cross 
metathesis reaction (Scheme 51, Scheme 52). 2-Substituted substrates 113a-b can be synthesised 
by allylation of an ester to give 117 followed by a Curtius rearrangement, while 3-substituted 
substrates 113c can be formed by allylation of a nitrile to give 122, followed by reduction and Cbz-
protection.  
 
Scheme 51: Retrosynthetic Analysis of 2-substituted cyclisation precursor 
 
Scheme 52: Retrosynthetic Analysis of 3-substituted cyclisation precursor 
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 9.2 Synthesis of the Pyrrolidine Precursors 
 
The synthetic route to the precursors started with the synthesis of the 2- and 3-substituted Cbz-
protected amines 115a-c (Scheme 53).  
 
Scheme 53: Structures of 2- and 3-substituted Cbz-protected amines 
For the 2-substituted amines the route proceeded via deprotonation of ester 123 using lithium 
diisopropylamide (LDA) as a strong base. The LDA was formed using diispropylamine and n-
butyllithium at -78 oC in dry tetrahydrofuran and the solution stirred for 45 min. The starting ester 
was then added and the resultant enolate was stirred for further 45 min at -78 oC; 1 eq of 4-
bromo-1-butene was then added at -78 oC and the reaction mixture was warmed to room 
temperature to give the ester 117 after purification. The ester 117 was then hydrolyzed under 
reflux conditions with 20% sodium hydroxide (aq) in methanol and then acidified with 1M 
hydrochloric acid to yield the carboxylic acid 116. The acid 116 underwent the Curtius 
rearrangement41 using diphenylphosphoryl azide and triethylamine in dry toluene at 90 oC to form 
the isocyanate and the reaction mixture was stirred for 2 h; 1.5 eq of benzyl alcohol was then 
added at 90 oC, the reaction was stirred for further 48 h at the same temperature to give the final 
Cbz-protected amine 116 after purification (Scheme 54). 
Scheme 54: Represantative reaction route to 2-substituted Cbz-amines 
The route to the 3-substituted amines began with deprotonation of the nitrile 124, a procedure 
similar to deprotonating the ester 123 as mentioned above, using LDA at -78oC in dry THF to give 
the nitrile anion which was reacted with allyl bromide to give substituted nitrile 122. The nitrile 
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was then reduced using lithium aluminium hydride as the reducing agent. The free amine was 
delivered upon Fieser workup42 121 and it was Cbz-protected43 115c with benzyl chloroformate 
following a standard procedure (Scheme 55).  
Scheme 55: Represantative reaction route to 3-substituted Cbz-amines 
Following the successful synthesis of the 2,3-substituted Cbz-amines, the next step for the “Clip-
Cycle” methodology was to make the activating group, the p-tolyl thioacrylate 118.44 The 
synthetic route proceeds with deprotonation of the thiol 119 by treating it with sodium 
borohydride and 15% sodium hydroxide to form the sodiated salt of p-thiocresol 125. The 
reaction was stirred in room temperature for 3 hours and sodium borohydride used to prevent 
the formation of disulfides. To this, a solution of acryloyl chloride and 2,4,6-butylated 
hydroxytoluene (BHT) dissolved in cyclohexane was added and the reaction was stirred for 35 min 
at 55 oC. The addition of BHT helped prevent radical polymerization of the thioester through 
oxidation of thiol and the p-tolyl thioester was obtained in moderate yield (Scheme 56). 
 
Scheme 56: Synthesis of the thioacrylic acid S-p-tolyl ester 
With the synthesis of the thioacrylate 118 and the Cbz-amines 115a-c complete, the synthesis of 
the cyclisation precursors 113a, 113b and 113c was attempted via an alkene cross metathesis 
reaction45 (Scheme 57, Scheme 58). The reaction conditions have already been optimized within 
the Clarke group46 and the synthesis of the precursors was successful. The unsaturated Cbz-
amines 115a, 115b, 115c were “clipped” in a 1:3 ratio with the thioester 118 using Hoveyda 
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Grubbs II catalyst (10 mol%) 126 and Copper(I)  iodide (1 eq) as a co-catalyst in 1,2-dichloroethane 
(1,2-DCE) at 50 oC  to yield the cyclisation precursors 113a-c.   
 
Scheme 57: Cross metathesis reaction for 2-substituted precursors 
 
Scheme 58: Cross metathesis reaction for 3-substituted precursor 
                                          
Figure 10: Hoveyda Grubbs II Catalyst 
A key part of this project was the asymmetric cyclisation using chiral phosphoric acids and 
determination of the enantioselectivities of the pyrrolidine products. Therefore, it was necessary 
to investigate the conditions required to resolve these mixtures. Chiral chromatography refers to 
the separation of enantiomers using an HPLC column that is packed with a chiral stationary phase. 
The enantiomers are separated based on the interactions that occur during their exposure to the 
chiral stationary phase. The stronger the interactions between the enantiomers and the polar 
stationary phase the longer the elution time. The interaction strength depends on the functional 
groups of the enantiomers structure, with more polarized groups (e.g., hydroxyl-) and groups 
capable of hydrogen bonding inducing more retention.  Each compound was resolved using 
various columns (CHIRALPAK IA/IB/IC/IG), and using different eluent concentrations 
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(hexane:isopropyl alcohol (IPA)) , flow rates and temperatures as the shown in the figures and 
table below (Figures 11-13, Table 10-15). 
 
Firstly, the synthesis of 2-phenyl-substituted precursor 113a started from using 1 eq of 115a and 
3 eq of 118 (Scheme 59). The resulted 113a was yielded successfully after purification. Then 
attempts were made to resolve the two enantiomers of 113a and it resolved successfully on IA 
column (40 oC), at 80:20 hexane:IPA, giving separation of enantiomers  as two sharp peaks (Figure 
11, Table 10-11). However, two equal ‘unknown’ peaks with retention times at approximately 9 
min and 11 min seemed to appear in every HPLC trace as seen in the figure below. The ‘unknown’ 
peaks were separated and determined via mass spectrometry to be cyclized product 114a of the 
113a precursor. However, the 114a had already been purified by flash column chromatography 
and analyzed by NMR spectroscopy (1H, 13C), showing no cyclized product present.   That unusual 
cyclisation effect was tried to be explained and different suggestions were given. One suggested 
that the precursor was cyclizing inside the HPLC chiral column. The HPLC columns that were used 
are CHIRALPAK immobilized columns and the chiral stationary phases are amylose-based. 
Interactions between the polysaccharide stationary phase and the precursor could lead to 
cyclisation. Another suggestion was that the precursor was actually cyclizing in the solution of 
eluent, hexane:IPA, when preparing the HPLC sample. Isopropyl alcohol has the polar –OH group 
in its’ molecule and it could cause intermolecular hydrogen bonding interactions with the 
precursor. In conclusion the solution of eluent upon preparing HPLC samples was needed to be 
changed  to a less polar solvent, the dichloromethane to prevent the cyclisation.  
 
 
Scheme 59: Cross metathesis reaction for 115a 





Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113a IA 80:20 1 40 













Figure 11: HPLC trace of 113a precursor 
Racemic 
Substrate 
Peak 1 (Retention 
time/ min) 




114a 10.421 2.9689 11.520 2.5287 
113a 16.112 46.8853 17.877 46.5204 
Table 11: Retention times of 113a precursor 
 
 






Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113b IC 80:20 1 40 










Figure 12: HPLC trace of 113b precursor 





































Peak 1 (Retention 
time/ min) 




113b 14.511 33.5600 16.600 33.5070 
Table 13: Retention times of 113b precursor 
 
 





Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113c IB 80:20 1 40 
Table 14: HPLC conditions of racemic 113c precursor 
 












Peak 1 (Retention 
time/ min) 




113c 16.433 43.8099 18.741 43.7306 
Table 15: Retention times of 113c precursor 
 




















Following the encouraging results of the synthesis and analysis by chiral HPLC, the cyclisation 
precursors 113a-c were subjected to cyclisation conditions under racemic and asymmetric 
conditions to study their enantioselectivities. 
 
9.3 Brønsted Acid Catalyzed Cyclisation of Pyrrolidine Precursors 
 
Based on previous projects within the Clarke group36,37, the racemic cyclisation of the pyrrolidine 
precursors proceeded using camphorsulfonic acid (CSA) as the Brønsted acid. The protected 
amine nitrogen in the presence of a Brønsted acid proceeds to attack the β-position of the of α,β-
unsaturated thioester sidechain which forms the substituted pyrrolidines. The Brønsted acid 
catalysed cyclisation generates racemic products, which are used to form the substituted 
pyrrolidines used to screen chiral HPLC conditions. These are then used, to compare and measure 
the enantiomeric excess (% ee) of the pyrrolidines formed under asymmetric conditions using 
chiral Brønsted acid catalysts. The cyclisations of 113a-c were attempted with an excess of 3 eq 
CSA using 1, 2-DCE as solvent and were carried out at 50 oC for 24h (Scheme 62). 
 
Scheme 62: Cyclisation of 113a-c precursors using CSA                                                  
Following the synthesis of the substituted pyrrolidines 114a-c, the racemic products were 
analyzed using chiral HPLC to resolve the enantiomers. Similar to resolving the enantiomers of 
their precursors, the pyrrolidines were subjected to various concentrations of the eluents 
(Hexane:IPA) and various chiral chromatography columns (CHIRALPAC IA/IB/IC/IG). The conditions 
used for each substituted pyrrolidine are summarized in the table and figures below.(Figure 14-
16, Table 16-21). 
The two enantiomers of the 2-phen-substituted pyrrolidine 114a appear as two equal peaks with 
retention times at 10 and 12 minutes respectively and it confirms the previous observation that 
the 2-phen-precursor cyclized in the eluent solution (Figure 14). One more interesting observation 
was made upon trying to resolve the 3-phen-pyrrolidine 114c. Looking at the HPLC trace, the 
second sharp peak at 8.7 minutes has a small ‘shoulder’ underneath and one smaller peak 
appears at approximately 11.5 minutes. This hints that perhaps the four peaks correspond to the 
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four diastereomers and they were showing up on the HPLC trace upon resolution, but this 
observation was not proven (Figure 16).  
 





Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
114a IA 80:20 1 40 












Peak 1 (Retention 
time/ min) 




114a 10.086 51.6233 12.002 48.3767 
Table 17: HPLC retention times of racemic 114a pyrrolidine 
 
 
Scheme 64: Cyclisation of precursor 113b using CSA 
























Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
114b IC 80:20 1 40 





   
 




Peak 1 (Retention 
time/ min) 
Area% Peak 2(Retention 
time/ min) 
Area% 
114b 9.269 45.7837 12.048 38.8365 










Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
114c IB 80:20 1 40 
Table 20: HPLC conditions of racemic 114c pyrrolidine 
 





























Peak 1 (Retention 
time/ min) 




  114c 8.189 39.9611 8.763 50.2605 
Table 21: HPLC retention times of racemic 114c pyrrolidine 
 
 
With the HPLC conditions for the three substituted 113a-c precursors and their cyclized products 
114a-c set up, it was now possible to monitor the kinetic resolutions and observe the formation of 
the major enantiomer while the corresponding substrate enantiomer disappeared.  Before 
subjecting the precursors to the asymmetric cyclisation conditions, HPLC samples that consisted 
of a mixture of 113a-c precursor and cyclized product 114a-c (1:1) were resolved. This provided 
the opportunity to visualize where each peak should be while monitoring the asymmetric 
reaction. In the asymmetric reaction catalyzed by a chiral phosphoric acid, starting material was 
being consumed while product was being formed as the reaction progresses over time. As a 
result, in an HPLC trace of an aliquot of the reaction four peaks should appear; the first two peaks 
correspond to the cyclisation product and the following two peaks are the enantiomers of 
precursors. The cyclisation precursors are more polar than the cyclisation products due to the N-H 
group in their structure that is capable of hydrogen bonding with the stationery phase of the HPLC 
column and that agrees with the longer retention times. The three following HPLC traces were in 
agreement with the separated HPLC traces of cyclisation precursors and cyclisation products and 
the retention times match for each one of them. As expected, two equal peaks that corresponded 
to the racemic cyclisation products followed by two equal peaks of the racemic cyclisation 
precursors appeared in each HPLC trace (Figure 17-19, Table 22-25).  

























Peak 1 (Retention 
time/ min) 




114a 10.036 37.7868 11.702 37.5270 
113a 14.887 12.4931 17.435 12.1930 








Figure 18: HPLC trace of racemic 113b + racemic 114b 
Racemic 
Substrate 
Peak 1 (Retention 
time/ min) 




114b 9.230 3.4393 12.018 2.0902 
113b 14.765 16.1362 16.849 16.0152 





























































Peak 1 (Retention 
time/ min) 




114c 8.138 30.0749 8.704 35.8024 
113c 16.475 17.0817 18.774 17.0411 






Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113a + 114a  IA 80:20 1 40   
113b + 114b IC 80:20 1 40  
113c + 114c IB 80:20 1 40  
Table 25: HPLC conditions of racemic mixtures 113a-c, 114a-c 
 
9.4 Kinetic Resolutions of the Pyrrolidine Precursors 
 
The cyclisation 113a-c precursors were subjected to asymmetric kinetic resolutions using chiral 
phosphoric acids (CPA) as the chiral Brønsted acid catalysts. For this purpose of study, (R)-TRIP 
was used as the catalyst and cyclohexane as the solvent based on studies upon pyrrolidine 
substrates within the Clarke group37. It was found that (R)-TRIP and non-polar solvents like 
cyclohexane gave higher %ee’s and %yields compared to polar solvents like 1,2-DCE. The 
concentration of all the asymmetric reactions was kept at 0.02M with a catalyst loading of 20 
mol%. The conversion and %ee of the reaction were monitored at regular intervals using HPLC 
until conversion reached 50%. While following the evolution of the enantiomeric excess and the 
conversion, kinetic profiles for both the starting material and the product were built. During the 
asymmetric (R)-TRIP reactions, the same experimental procedure was followed: At regular 
























intervals, aliquots (0.1 – 0.2 mL) were obtained, quenched with a few drops of triethylamine and 
filtered through a microscale (pipette) column before being analysed by HPLC. These analyses 
allowed the monitoring of the formation of the products and the consumption of the starting 
materials through the time. Triple measurements analyzed by HPLC of each aliquot were taken 
and averaged. Once the reactions reached 50% conversion, they were quenched with 
triethylamine, and both enantioenriched product 114a-c and recovered starting material 113a-c 
were separated using flash column chromatography on silica and analysed by HPLC. The initial 
attempts of the kinetic resolutions were based on another kinetic resolutions’ project in the 
Clarke group that involved asymmetric synthesis of tetrahydropyrans and tetrahydrofurans36 
using chiral Brønsted acid as catalysts; (R)-TRIP was used as catalyst in cyclohexane and the 
reaction was done at 50 oC. The investigation began using these set of conditions. The background 
work based on this project though, relates to enantioselective synthesis of spirocyclic 
pyrrolidines37 and the asymmetric reactions were done in higher temperature, at 80 oC. For those 
reasons, the kinetic resolutions of our substrates were attempted at two different temperatures, 
50 oC and 80 oC.  
The study began with the 113a precursor (28.0 mg) using (R)-TRIP (20 mol %), cyclohexane as 
solvent, at 50 oC and the concentration kept at 0.02M (Scheme 66, Table 26, Figure 20-21). The 
reaction’s conversion and %ee were monitored by HPLC and aliquots were taken every 2 hours. 
Scheme 66: Kinetic resolution of 113a using 20 %mol (R)-TRIP at 50 oC 
 
 %Conversion %ee 
T(h) %P %SM %P %SM 
0 0 100 0 0 
1 12.81709 87.18291 54.07733 13.228746 
3 23.60179 76.39821 68.3402 32.470571 
5 33.52804 66.47196 72.07738 52.617081 
7 41.08277 58.91723 71.31912 70.716787 
9 52.04752 47.95248 69.02735 79.478799 





Figure 20: Conversion of Starting Material 113a and Product 114a 
 
 
Figure 21: %ee of Starting Material 113a and Product 114a 
 
The amount of starting material 113a decreased gradually over a 9 hour period while products’ 
increased smoothly. The reaction was quenched with trimethylamine upon both 113a and 114a 
were at ~50% conversion. Simultaneously, the starting material’s enantioenrichment improved 
gradually to 80% after 9 h and the product’s reached a maximum of 72% after 5 h but then began 
to decrease to 69%. This is due to the fact that the faster reacting enantiomer of the starting 
material is being consumed forming the desired product with high enantioselectivity; but when 
that is consumed, the slower reacting enantiomer starts interacting with the catalyst forming the 


































enantioenriched product to drop. The quenched reaction mixture was purified with flash column 
chromatography and 113a (5.8mg, 21% yield) and 114a (3.8mg, 14% yield) were isolated. The %ee 
of the cyclized product should correspond to 69% and the starting material to 80%. To our delight, 
the ee of the 114a (69%) and 113a (81%) were within experimental error. The selectivity factor at 
50% conversion of unreacted 113a was calculated and resulted in a value of s=32.28  
Following the kinetic results on the 113a precursor, the kinetic resolution was attempted at 80 oC 
using the same catalyst loading, solvent and concentration (30.0 mg of 113a), and aliquots were 
taken every 30 minutes (Scheme 67).   
Scheme 67: Kinetic resolution of 113a using 20 %mol (R)-TRIP at 80 oC 
 
 %Conversion %ee 
T(h) %P %SM %P %SM 
0 0 100 0 0 
0.5 21.38624 78.61376 40.73134 23.26898 
1 24.212 75.788 48.2298 26.97116 
1.5 42.21684 57.78316 60.85804 58.66683 
2 44.31505 55.68495 58.87981 74.86612 
2.5 48.04446 51.95554 57.36853 83.99958 
3 49.07859 50.92141 56.1521 87.44376 
3.5 50.84661 49.15339 54.85008 91.65985 





Figure 22: Conversion of Starting Material 113a and Product 114a 
 
 
Figure 23:  %ee of Starting Material 113a and Product 114a 
A similar pattern of the initial reaction was observed, the amount of starting material decreased 
evenly to 49% and the reaction was then quenched. The 113a decreased gradually over a 3 hour 
period while products’ increased smoothly and the reaction was quenched upon both 113a and 
114a were at 50% conversion.  At the same it, the 113a enantioenrichment reached 91% after 3.5 
h and the product’s reached 60% within 1.5 hours, but decreased to 54% upon 50% conversion as 
the slower reacting enantiomer started being formed. The quenched reaction mixture was 
purified with flash column chromatography and 113a (5.6mg, 19% yield) and 114a (4.9mg, 17% 
yield) were separated and analysed by HPLC with %ee’s that corresponded to 91% and 51% 





































were compared to the corresponding racemic products from both starting material and product. 
The major product enantiomer peak appeared at 11 min, while the starting material’s major 






Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113a+114a IA 80:20 1 40 












Minor Peak  
(Retention time/ 
min) 




114a 9.382 13.7030 11.327 77.8590 







Figure 25: HPLC trace of enantioenriched 113a 
 



































Minor Peak  
(Retention time/ 
min) 




113a 13.693 3.3976 16.445 68.4589 
Table 30: HPLC retention times of enantioenriched 113a 
 
Subsequently, the enantioenriched 113a was further cyclised to give the opposite enantiomer via 
the Brønsted acid catalyzed cyclisation, using camphorsulfonic acid as the Brønsted acid (Scheme 
68). The recovered 113a was reacted with 3 eq of camphorsulfonic acid, in 1,2-dichloroethane 
and the reaction was heated at 50 oC. After 24 h, the reaction was quenched with sodium 
bicarbonate solution, followed by purification with flash column chromatography and analysis 
with HPLC. The opposite enantiomer (6.0 mg)from that formed in the kinetic resolution reaction 
appeared at 9min and was obtained in good yield and in higher enantioselectivity (93%ee). The 
enantioselectivity of the opposite enantiomer 126 was comparable to the enantioselectivity of 
the recovered 113a and no racemization of the stereocentre of 113a appeared (Figure 26, Table 
31-32).  
 





Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
126 IA 80:20 1 40 
Table 31: HPLC conditions of enantioenriched 126 
 
 




Figure 26: HPLC trace of enantioenriched 126 


























Major Peak  
(Retention time/ 
min) 




126 9.318 86.6953 11.483 2.9274 
Table 32: HPLC retention times of enantioenriched 126 
 
Next, the kinetic resolution of 2-isopropyl-substituted 113b precursor was attempted using (R)-
TRIP at 50 oC and at 80 oC. The same experimental procedure was followed and reactions’ 
conversion and %ee were monitored by HPLC (Scheme 69-70). 
Starting with the asymmetric reaction at 50 oC, aliquots were taken every hour and some 
interesting observations were made. The amount of 113b decreased gradually to 48% over a 7 h 
period while product’s increased to reach 51% and the reaction was quenched with triethylamine. 
Quick enantioenrichment of 114b was observed after 2 h, from 0 to to 86%, yet it started  
decreasing as the reaction proceeded as the slower reacting enantiomer of starting material was 
also consumed. Upon 50% conversion, 114b %ee reached 74% while 113b enantioenrichment 
reached 61%. The quenched reaction mixture was purified with flash column chromatography and 
starting material and product were separated and analyzed by HPLC  (Figure 27-28, Table 33). The 
calculated s-factor for unreacted 113b at 50% conversion was s=8.  
Scheme 69: Kinetic resolution of 113b using 20 %mol (R)-TRIP at 50 oC 
 %Conversion %ee 
T(h) %P %SM %P %SM 
0 0 100 0 0 
1 9.615817 90.38418 85.65735 8.73545 
2 16.00781 83.99219 86.4917 16.44936 
3 22.98422 77.01578 83.51349 26.60197 
4 30.10243 69.89757 80.85213 36.43961 
5 32.62789 67.37211 79.14571 45.24952 
6 37.02069 62.97931 77.08291 54.17577 
7 51.1251 48.8749 74.61255 61.10019 





Figure 27: Conversion of Starting Material 113b and Product 114b 
 
 
Figure 28: %ee of Starting Material 113b and Product 114b 
 
For the asymmetric reaction of 113b at 80 oC, aliquots were taken every 30 minutes and a similar 
pattern was observed. The amount of conversion of starting material decreased steadily to 51% 
within 3 hours and the reaction was quenched with triethylamine. The enantioenrichment of 
114b rapidly jumped from 0 to 90% within 30 minutes, but it reached 65% as the reaction 
proceeded to 50% conversion and enantioenrichment of 113b was 70%. The quenched reaction 
mixture was purified with flash column chromatography and 113b (23.0 mg, 35% yield) and 114b 
(39.0 mg, 60% yield) were separated and analyzed by HPLC. The enantioenrichment  of starting 






































experimental errors. The HPLC traces were compared to the corresponding racemic products 
from both 113b and 114b. The major product enantiomer peak appeared at 9 min, while the 
starting material’s major enantiomer appeared at 15 min (Figures 29-32, Table 34-36).The 
selectivity of unreacted 113b at 50% conversion was s=9.  
Scheme 70: Kinetic resolution of 113b using 20 %mol (R)-TRIP at 80 oC 
 
 %Conversion %ee 
T(h) %P %SM %P %SM 
0 0 100 0 0 
0.5 12.08216 87.91784 90.38418 12.21585 
1 25.58742 74.41258 77.76875 29.98132 
1.5 31.68066 68.31934 76.65931 41.77613 
2 36.73414 63.26586 74.07198 51.34859 
2.5 47.33961 52.66039 70.98555 60.2819 
3 48.04921 51.95079 65.06756 70.00516 
Table 34: Conversion and %ee of Starting Material 113b and Product 114b 
 
 





























Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113b + 114b  IC 80:20 1 40  


























%ee of Starting Material & Product 
 
%P %SM









































Major Peak  
(Retention time/ 
min) 




114b 9.475 45.0795 12.471 12.8108 
113b 15.221 80.0310 17.448 6.7495 
Table 36: HPLC retention times of enantioenriched 113b+114b 
 
Furthermore, the opposite enantiomer was obtained in moderate yield and %ee. The 
enantioenriched 113b was cyclised via the Brønsted acid catalyzed cyclisation, with 3 equivalents 
of camphorsulfonic acid in 1,2-dichloroethane at 50 oC  (Scheme 71). After 24 h, the reaction was 
quenched with sodium bicarbonate solution, purified with flash column chromatography followed 
by analysis with HPLC. The opposite enantiomer 127 (8.0 mg) appeared at 12 min and was 
obtained in moderate yield and enantioselectivity (61% ee). In comparison with the enantiomer 
formed in the asymmetric kinetic reaction, the enantioselectivities of the opposite enantiomers 
are almost identical (63% ee for 114b, 61% ee for 127). A slight racemization of the 
enantioenriched recovered 113b (74% ee) occurred that led to 61% ee of the product formed 
(Figure 33, Table 37-38). 
 






Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
127 IC 80:20 1 40 




















Minor Peak  
(Retention time/ 
min) 




127 9.229 18.2519 12.170 75.7477 
Table 38: HPLC retention times of enantioenriched 127 
 
The last set of kinetic resolutions was performed on the 3-phenyl substituted precursor 113c 
(26mg). Similarly to the other substrates, (R)-TRIP and cyclohexane were used in different 
temperatures (50 oC and 80 oC) to study the enantioselectivity of the asymmetric reactions. 
However, when the temperature was set at 80 oC, the reaction proceeded too quickly for us to 
monitor. The conversion of 113c dropped below 50% within the first hour of the reaction, making 
it difficult for us to monitor it. Following that, the asymmetric reaction was conducted at 50 oC; 
aliquots were taken every 30 minutes and analyzed by HPLC (Scheme 72, Figures 34-35, Table 39). 
The reaction was quenched with triethylamine after 5 hours, when 43% of 113c was left. The 
enantioselectivity of product increased to 67% within the first hour, but decreased to 40% upon 
56% conversion, while starting material was recovered with 83% ee. The reaction mixture was 
separated with flash column chromatography and both 113c (11.0 mg, 42%yield) and 114c (14.0 
mg, 54% yield) were analyzed by HPLC (Figures 36-37, Table 40-41). The enantioenrichment of 
starting material and product corresponded to 85% and 32% respectively and the values were 
between experimental errors. The HPLC traces were compared to the corresponding racemic 
products from both 113c and 114c. The major product enantiomer peak appeared at 7 min, while 
the starting material’s major enantiomer appeared at 12 min. The s-factor for 113c at 50% 
conversion was calculated at s=55.  
















Scheme 72: Kinetic resolution of 113c using 20 %mol (R)-TRIP at 50 oC 
 %Conversion %ee 
T(h) %P %SM %P %SM 
0 0 100 0 0 
1 12.40826 87.59174 67.42561 16.87628 
2 25.299 74.701 59.12057 37.87456 
3 43.37921 56.62079 55.28492 56.59632 
4 49.99723 50.00277 46.50439 71.40204 
5 56.84682 43.15318 40.9017 83.64721 
Table 39: Conversion and %ee of Starting Material 113c and Product 114c 
 
 































Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
113c+114c IB 80:20 1 40 
Table 40: HPLC conditions of enantioenriched 113c+114c 
 
 





















%ee of Starting Material & Product 
%P %SM























Figure 37: HPLC trace of enantioenriched 113c 
Enantioenriched 
Substrate 
Minor Peak  
(Retention time/ 
min) 




114c 7.278 51.9636 7.873 26.4718 
113c 11.020 6.8418 12.401 82.8710 
Table 41: HPLC retention times of enantioenriched 113c+114c 
Furthermore, the opposite enantiomer was obtained in good yield and %ee (Scheme 70). The 
enantioenriched 113c was further cyclised via the Brønsted acid catalyzed cyclisation, with 3 
equivalents of camphorsulfonic acid in 1, 2-dichloroethane and the reaction was heated at 50 oC. 
After a period of 24 h, the reaction was quenched with sodium bicarbonate solution, purified with 
flash column chromatography and the product 128 (7.0 mg , 80% yield) was analyzed by HPLC 
(Figure 38, Table 42-43).  The opposite enantiomer from that formed in the kinetic resolution 
reaction appeared at 8 min in higher enantioselectivity (86% ee) than the other enantiomer (32% 
ee).  No racemization of the enantioenriched recovered 113c (85% ee) occurred. 
 





Hexane:IPA Flow rate 
(mL/min) 
Temperature 
( oC ) 
128 IB 80:20 1 40 
Table 42: HPLC conditions of enantioenriched product 128 
 























Figure 38: HPLC trace of enantioenriched 128 
Enantioenriched 
Substrate 
Minor Peak  
(Retention time/ 
min) 




128 7.979 5.8409 8.805 72.0642 
Table 43: HPLC retention time of enantioenriched 128 
 
In conclusion, the asymmetric synthesis via kinetic resolutions of substituted pyrrolidines using 
the chiral phosphoric acid (R)-TRIP was successfully studied. The kinetic studies for all the three 
different substrates were conducted in two different temperatures (50 oC and 80 oC), but in the 
same solvent (cyclohexane) and same catalyst loading ((R)-TRIP 20 %mol) while the concentration 
was kept at 0.02M. Enantioenriched product and recovered starting material were obtained in 
good and moderate enantioselectivities as well as the opposite enantiomer of the product.  
 
9.5 Determination of stereochemistry 
 
It was hoped that the absolute stereochemistry could be determined by X-ray 
crystallographyScheme 74).  The thioester functionality is essential for the cyclisation step and it is 
also a versatile handle for further transformations. Thioesters can be converted directly to 
alcohols, aldehdyes, amides, esters and ketones under very mild conditions.47 In the scheme 
below, are shown the potential routes we could follow to get a crystalline compound.  




















Scheme 74: Plan of determination of absolute stereochemistry 
The first plan was to reduce the thioester group using a reducing agent, such as lithium aluminium 
hydride (LiAlH4)
48 and reacting the formed alcohol 129 with 4-bromobenzoyl chloride to form the 
ester 130. Another possible route, was to convert the thioester group to an aldehyde or a ketone 
and trap the carbonyl group C=O with a hydrazine such as 2,4-dinitrophenylhydrazine and 
crystallize the formed 132. By incorporating a heavy atom such as bromo- or nitro- groups crystals 
could be isolated for X-ray crystallographic analysis, permitting the determination of the absolute 
stereochemistry of 114.  
An initial attempt involved treating 114c with LiAlH4 to reduce the thioester group to the 
corresponding alcohol 129 (Scheme 75).  Approximately, 20 eq of LiAlH4 were added to a solution 
of 114c in dry diethyl ether and the reaction was cooled down to 0 oC. After stirring for 30 min in 
that temperature, the reaction was warmed to room temperature and was heated with reflux 
conditions overnight. The Fieser workup42 was followed to quench and workup the reaction 
mixture. Unfortunately, analysis of the crude reaction mixture by 1H NMR and Mass spectroscopy 
resulted in complexes spectrums with no evidence for the formation of 129.  
 
Scheme 75: Attempted synthesis of alcohol 129 
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Next, the reduction of the thioester to the alcohol 129 reaction was repeated, but we envisaged 
leaving the reaction stirring in room temperature instead of heating under reflux (Scheme 76). 
Similar experimental procedure was followed, 20 eq of LiAlH4 were added to a solution of 114c in 
dry diethyl ether and the reaction was cooled down to 0 oC. After stirring for 30 min in that 
temperature, the reaction was warmed to room temperature and left stirring overnight. The 
reaction mixture was monitored by thin layer chromatography (TLC) until the 114c was consumed 
and the TLC analysis indicated the presence of several different products. The Fieser workup was 
followed to quench and workup the crude reaction mixture, which was then analysed by by 1H 
NMR and Mass spectroscopy. However, the complex spectrums showed no evidence of alcohol 
129.   
 
Scheme 76: Attempted synthesis of alcohol 129 
Due to the failed reduction reactions, alternative routes were tried to reduce the thioester group 
to aldehyde 131 by using the bulky reducing agent, di-isobutyl aluminum hydride (DIBAL-H) 
(Scheme 77). In a solution of 114c in dry tetrahydrofuran in -78 oC, was added 1 eq of DIBAL-H and 
the reaction was stirred for 1 h in that temperatue. The reaction progression was followed by TLC 
until full conversion of 114c. Analysis of the crude reaction mixture by 1H NMR spectroscopy and 




Scheme 77: Attempted synthesis of aldehyde 129 
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It was decided to repeat the reaction to form the 129 but using 3 eq of the reducing agent DIBAL-
H, instead of 1 eq (Scheme 78). In a solution of 114c  in dry tetrahydrofuran in -78 oC, was added 1 
eq of DIBAL-H and the reaction was stirred for 1 h in that temperature. When TLC monitoring 
showed full conversion of 114c the crude mixture was analysed by 1H NMR and mass 
spectroscopy. Disappointingly, no aldehyde peak was observed. 
 
Scheme 78: Attempted synthesis of aldehyde 129 
 The  final reaction of the thioester group to a ketone was attempted, using a Pd(0) catalyst for a 
Liebeskind–Srogl type coupling reaction.49 Liebeskind–Srogl proposed a new reaction for the 
synthesis of ketones, as shown in the scheme below. The palladium-catalysed cross-coupling 
reaction between a thioesters 133 and boronic acids 134 proceeded in the presence of a copper 
co-catalyst to generate the corresponding ketones 135(Scheme 79). 
 
Scheme 79: Liebeskind–Srogl coupling reaction 
In this case, a preparation previously developed in the Clarke group for the synthesis of 
Diospongin A was followed.50 The palladium pre-catalyst which we used was Pd2(dba)3 with a 10 
mol % catalyst loading. The rest of the reagents and conditions used were 3 eq of copper(I)-
thiophene-2-carboxylate (CuTC), 8 mol % of triethyl phosphite ((EtO)3P) and 3 eq of  
phenylboronic acid (PhB(OH)2) (3.0 eqv) in dry tetrahydrofuran. The reaction was stirred at room 
temperature stirred for 18 h.  Unfortunately, these conditions resulted in the formation of many 




Scheme 80: Liebeskind–Srogl coupling reaction between phenylboronic acid and 114c 
In a publication by Farwick26 reported syntheses of various pyrrolidine derivatives through a 
domino hydroformylation/Wittig olefination, followed by an aza-Michael addition (Scheme 81). 
They, also, reported that the trans-configuration of 2,5-substituted pyrrolidines 138 was generally 
preferred at a reaction temperature of -78 oC upon use of potassium tert-butoxide (t-BuOK) as 
base.  The aza-Michael reactions yielded the 138 with KO-t-Bu (0.8 equiv.) at -78 oC in 
tetrahydrofuran as solvent and the reactions were stirred for 20 min. The trans-diastereoisomers 
were obtained in good to excellent yields (77–97%), with high enantiomeric excess (94-97%).   
 
Scheme 81:  Intramolecular aza-Michael reaction 
One of the 2,5-disubstituted pyrrolidine products that they reported was similar to one of 
pyrrolidine products that was synthetised, the 114a , as shown in the scheme below (Scheme 82). 
The Boc-protected pyrrolidine ring has trans-diastereoselectivity; it was envisaged that the 
stereochemistry could be determined by a 1H NMR comparison between  the pyrrolidine 114a 
product and the pyrrolidine 138a from literature.  
 
Scheme 82: Intramolecular aza-Michael reaction 
In order to directly compare the stereochemistry of the compounds against 138a  the thioster 
needed to be converted in a methyl ester. . A report by Hanessian38 used a method with silver 
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trifluoromethanesulfonate (AgOTf) in methanol:dichloromethane (MeOH/CH2Cl2) to convert a 
thiophenyl ester into a methyl ester. Using this procedure the methyl ester was generated in 
moderate yield (Scheme 83). To a solution of 114a in 1:1 MeOH:CH2Cl2 were added 3 eq of AgOTf 
and the reaction was stirred for 3 h in room temperature, followed by purification with flash 
column chromatography.  
 
Scheme 83: Methyl ester 139 synthesis 
In addition, the aza-Michael cyclisation reaction conditions by Farwick were followed to  
synthetise the 2,5- disubstituted pyrrolidine 140, using the 2-phen precursor 113a (Scheme 84). A 
solution of 113a in dry tetrahydrofuran was cooled to -78 oC and 0.8 eq of KO-t-Bu was added and 
the mixture stirred for 1 h, when thin layer chromatography (TLC) showed full conversion. The 
reaction was then quenched with saturated aqueous ammonium chloride solution and was 
purified by flash column chromatography to yield the 140 (70% yield).  
 
Scheme 84: Intramolecular aza-Micheal cyclisation reaction 
Synthesizing the pyrrolidine 140 using the t-BuOK cyclisation procedure provide the opportunity 
to compare the 140 and the 114a pyrrolidine from the chiral phosphoric acid cyclisation and see 
whether the data matches or not.  .  Looking at the 1H NMR spectra, the data between the two 
different products were consistent (Figure 39-42).  
The "quartet" at 5.17 ppm, are actually 2 doublets at 5.17 ppm (J=16 Hz) and 5.13 ppm (J=16 Hz) 
were from the one rotamer of Cbz group (H-17). The other rotamer of the Cbz group was the two 
doublets at 5.01 ppm (J=12 Hz) and 4.87 ppm (J=12 Hz). The resonance for H-11 was at also at 
5.01 ppm overlapping one half of the Cbz-doublet and this signal is a multiplet. The H-8 proton 





Figure 39: 1H NMR (CDCl3) spectrum of 114a 
 
 
Figure 40: 1H NMR (CDCl3) spectrum of 140 
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The two doublets at 3.49 ppm and 3.45ppm and the two doublets at 3.24 ppm and 3.20 ppm with 
a coupling constant of J=3 Hz were assigned as one H-7 proton. The second H-7 proton was 
assigned as the multiplet at 2.84-2.70 ppm. One H-10 proton overlapped with the three H-1 
protons as the multiplet at 2.46-2.32 ppm; the second H-10 proton was assigned as the multiplet 
at 2.22-2.12 ppm. The two H-9 protons were assigned as the two multiplets at 1.86 ppm and 1.78 
ppm respectively (Figure 41-42). 
 





Figure 42: 1H NMR (CDCl3) spectrum of 140 
 
Following the data comparison of the two pyrrolidine rings, the next step was the conversion of 
the thioester group of 140 to its’ methyl ester (Scheme 85). To a solution of 140 in 1:1 
MeOH:CH2Cl2 were added 3 eq of AgOTf and the reaction was stirred for 3 h in room temperature, 
followed by purification with flash column chromatography to yield the 141. 
 
Scheme 85: Methyl ester 141 synthesis  
Synthesizing the pyrrolidine 141 provided the opportunity to compare the 141 from the t-BuOK 
cyclisation procedure and the 114a pyrrolidine from the chiral phosphoric acid cyclisation and see 
whether the data matches or not.  Once again, the 1H NMR data between the two different 





Figure 43: 1H NMR (CDCl3) spectrum of 139 
  





Figure 45: 1H NMR (CDCl3) spectrum of 139 
 
Figure 46: 1H NMR spectrum of 141 
Looking at the 1H NMR spectra, the peaks at 7.37-6.78 ppm were assigned as the aromatic 
protons. The "quartet" at 5.17 ppm, which were actually 2 doublets at 5.17 ppm (J=16 Hz) and 
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5.13 ppm (J=16 Hz) were from the one rotamer of Cbz group (H-13). The other rotamer of the Cbz 
groups was the two doublets at 5.01 ppm (J=12 Hz) and 4.87 ppm (J=12 Hz). The H-13 was at also 
at 5.01 ppm overlapping one half of the Cbz-doublet and this signal is a multiplet. The H-4 proton 
was assigned as the multiplet in 4.65-4.55ppm.  The three H-1 were assigned as two singlets at 
3.70 ppm and 3.67ppm. The two doublets at 3.18 ppm and 3.14 ppm correspond to the major and 
the minor rotamer respectively and the two doublets at 2.96 ppm and 2.93 ppm with a coupling 
constant of 3Hz were assigned as one H-3 proton. One H-6 proton overlapped with the other H-3 
proton as the multiplet at 2.46-2.30 ppm; the second H-6 proton was assigned as the multiplet at 
2.22-2.12 ppm. The two H-5 protons were assigned as the multiplet at 1.82-1.70 ppm. 
In the literature procedure, the NMR (1H, 13C) analysis of compounds was conducted in 500 MHz 
at 90 oC and in toluene-d8 as the solvent. However, due to laboratory facilities shut down by the 
COVID-19 pandemic definitive proof could not be obtained. It can be assumed that the absolute 
stereochemistry is trans- for the 2-phenyl and 2-isopropyl substituted pyrrolidine rings as the data 
is consistent upon 1H NMR analysis (400 MHz, CDCl3). 
 
 
9.6 Conclusions and future work 
 
The synthesis of the racemic pyrrolidine cyclisation precursors 113a-c was achieved in good yields 
via a Hoveyda-Grubbs catalyzed metathesis reaction; the unsaturated Cbz-protected (115a-c) 
amines were ‘clipped’ with the thioacrylate 118 The Brønsted acid catalyzed cyclisation using CSA 
was carried out and generated the racemic substituted pyrrolidines 114a-c in good yields. The 
racemic pyrrolidine precursors and the corresponding cyclisation products were successfully 
screened under chiral HPLC conditions.  
The kinetic resolution studies of the pyrrolidine cyclisation precursors 113a-c using the chiral 
phosphoric acid (R)-TRIP were successful and was achieved with good to moderate selectivity.  
Both recovered enantioenriched starting material and product were isolated with good to 
moderate enantioselectivities; enantioenriched starting material was further cyclised under CSA 
conditions to yield the opposite enantiomer. It was found that the increase in temperature had an 
accelerating effect on the asymmetric cyclisation reactions, reaching the desirable 50% 
conversion within a few hours.  
The resolution process of the 2-phenyl pyrrolidine 113a precursor yielded in high 
enantioselectivity for the unreacted 113a (90% ee) and in high selectivity (s-factor= 122).The 
pyrrolidine 114a was afforded in low enantiomeric excess (51%ee) upon 50% conversion after 3.5 
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hours at 80 oC. The 3-phenylprecursor 113c was resolved in lower selectivity (s-factor=55); the 
enantiomerically enriched 113c was obtained with 85%ee and the corresponding  pyrrolidine 114c 
in 32% ee. The asymmetric reaction reached 50% conversion within 5 hours and the temperature 
was kept at 50 oC. The opposite enantiomers 126 and 128 were generated in good 
enantioselectivities under further CSA cyclisation conditions. The recovered 113a and  113c were 
further cyclized under CSA conditions to generate the corresponding opposite 126 and  128 
enantiomers and no racemization of the 113a and  113c occurred. The 2-isopropyl  precursor 
113b underwent a less effective kinetic resolution (s-factor=9) with moderate enantiomeric 
excesses for the recovered 113b (74% ee) and the corresponding pyrrolidine 114b (63% ee) upon 
reaching 50% conversion after 3 hours.  
The determination of the absolute stereochemistry was carried out by a 1H NMR comparison 
between our 2-phenyl pyrrolidine product (114a) and the 2-phenyl pyrrolidine (138a) from 
literature. In the publication it was reported that the trans-configuration of 2, 5-disubstituted 
pyrrolidines was preferred upon optimized cyclisation conditions. Using the optimized conditions 
from the literature (KO-t-Bu as a base, in – 78 oC) the 2-phenyl pyrrolidine 139 was synthesised in 
good yield (70% yield).  In order to directly compare the stereochemistry of 114a 140, the 
thioester groups were converted into the methyl ester groups (139, 141) Finally, the data from 1H 
NMR in CDCl3 analysis between the pyrrolidines 114a and 139  from the chiral phosphoric acid 
cyclisation and the pyrrolidines 140 and 141 from the KO-t-Bu cyclisation was consistent.  
It can be assumed that the ‘Clip-Cycle’ methodology proceeds with trans-configuration for the 
2,5-disubstituted pyrrolidines (11a, 114b). Definitive proof was not obtained, due to Spring 2020 
COVID-19 shutdown of laboratory facilities. 
In conclusion, ‘Clip-Cycle’ methodology can be used to generate enantiomerically pure substituted 
pyrrolidine rings with moderate to good yields and %ee’s via a kinetic resolution reaction. Both 
enantiomers of can be obtained; one from the asymmetric chiral phosphoric acid cyclisation, the 
opposite one from the Brønsted acid catalyzed cyclisation of the recovered pyrrolidine precursor.  
Future work would include kinetic resolutions of a broader pyrrolidine precursor scope using the 
‘Clip-Cycle’ methodology. The absolute stereochemistry of the enantioenriched 2- and 3- 
substituted products would need to be determined with X-ray crystallography.  
Additionally, the scope could be further extended by studying a dynamic kinetic resolution on 




Scheme 86: A dynamic kinetic resolution 
A dynamic kinetic resolution overcomes the drawback of the classical resolution and it is 
theoretically possible to obtain 100% yield of the desired enantiomers. The substrate is 
continuously isomerized during the resolution process and in this way the non-reacting 






















10.1 General Experimental 
 
Unless otherwise noted all compounds were bought from commercial suppliers and used without 
further purification. Nuclear magnetic resonance spectra were recorded on a Jeol ECS-400 
spectrometer at ambient temperature and spectra were processed using MestreNova.Chemical 
shifts are quoted in parts per million (ppm) and were referenced as follows: chloroform-d, 7.26 
ppm for 1H NMR; chloroform-d, 77.0 ppm for 13C NMR. Coupling constants (J) are quoted in Hertz. 
Infra-red spectra were recorded on an ATI Mattson Genesis FT-IR spectrometer. Mass 
spectrometry was performed by the University of York mass spectrometry service using electron 
spray ionisation (ESI) technique. Thin layer chromatography was performed on aluminium sheets 
coated with Merck Silica gel 60 F254. The plates were developed using ultraviolet light, acidic 
aqueous ceric ammonium molybdate or basic aqueous potassium permanganate. Liquid 
chromatography was performed using forced flow (flash column) with the solvent systems 
indicated. The stationary phase was silica gel 60 (220–240 mesh) supplied by Sigma-Aldrich. Dry 
solvents were acquired from PureSolv alumina columns from Innovative Technologies. High 
Performance Liquid Chromatography (HPLC) was performed using an Agilent 1200 series 
instrument using the chiral columns indicated and a range of wavelengths from 210-280 nm for 
detection. All other solvents and reagents were used as received from commercial suppliers. All 
numbering on the structures below is for the benefit of characterisation and does not necessarily 
conform to IUPAC rules. For a few compounds, full characterisation was not obtained due to the 












10.2 Experimental procedures 
 
 
To a solution of diisopropylamine (1.51 ml, 10.78 mmol ) in dry THF (5 ml) at -78 °C under N2 was 
added n-BuLi (1.42M, 7.60 mL ) and the solution was stirred for 45 mins. A solution of methyl 2-
phenylacetate (1.41 mL, 10.00 mmol ) in dry THF (5 ml) was added  over 2 minutes at -78 °C and 
the reaction was stirred for 45 mins. 4-bromo-1-butene (2 ml, 20 mmol) was added over 1 min at -
78 °C and the reaction warmed to room temperature. The reaction was stirred overnight and 
quenched with 1 M aq. HCl (10 ml). The reaction was extracted with diethyl ether (3 x 30 mL), the 
organic fractions were combined, washed with saturated brine solution (30 ml), dried with 
MgSO4, filtered and in vacuo. The crude residue was purified by flash column chromatography (1% 
EtOAc/hexane) to afford 117a as colorless oil (1.21 g, 5.92 mmol, 59% yield).  1H NMR (400 MHz, 
Chloroform-d): δ 7.29 – 7.17 (5H, m, H-Ar), 5.74 (1H, dddd, J = 16.8, 12.7, 6.5, 2.1 Hz, H-2), 5.01 – 
4.92 (2H, m, H-1), 3.57 (3H, s, H-7), 3.53 (1H, dd, J= 7.5 Hz, 2.1 Hz, H-5), 2.21 – 2.09 (1H, m, H-4), 
2.00 – 1.94 (2H, m, H-3), 1.90 – 1.80 (1H, m, H-4) ppm;  13C NMR (101 MHz, Chloroform-d): δ 
174.41 (C-6), 139.12 ( C-8), 137.66 (C-2), 128.78 (C-10), 128.11 (C-9), 127.40 (C-11), 115.56 (C-1), 
51.96 (C-7), 50.83 (C-5), 32.68 (C-4), 31.64 (C-3) ppm; HRMS (ESI): 205.121550 (M+ H+ , C13H17O2 
requires 205.122306). IR (ATR) characterisation was not obtained due to the Spring 2020 COVID-
19 shutdown of laboratory facilities. 
 
 
Compound 117b was synthesised using the same procedure as 117a with diisopropylamine (1.54 
mL, 10.98 mmol), n-BuLi (1.98 M, 5.56 mmol), ethyl isovalerate (1.50 ml, 9.96 mmol) and 4-
bromo-1-butene (2 ml, 20 mmol). 117b yielded as colorless oil (416.48 mg, 2.26 mmol, 23% 
yield).1H NMR (400 MHz, Chloroform-d): δ 5.78 (1H, dddd, J = 17.0 Hz, 10.2 Hz, 6.8 Hz, 6.8 Hz Hz, 
H-2),4.93 (1H, ddd, J = 16.8 Hz, 1.2 Hz, 1.2 Hz, H-1 ), 4.87 (1H, bd, J = 10.3 Hz), 4.07 (2H, q, J = 7.1 
Hz, H-9), 2.06 (1H, ddd, J = 14.0 Hz, 7.4 Hz, 3.8 Hz, H-5), 2.01 – 1.93 (1H , m, H-3), 1.92 – 1.83 (1H, 
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m, H-3), 1.78 (1H, apparent dq, J = 13.8 Hz , 6.9 Hz, H-6), 1.70 – 1.58 (1H, m, H-4), 1.55 – 1.44 (1H, 
m, H-4 ), 1.19 (3H, t, J = 7.0 Hz, H-10), 0.86 (3H, d, J = 8.4 Hz), 0.84 (3H, d, J = 8.4 Hz); 13C NMR (101 
MHz, Chloroform-d) : δ  175.69 (C-8) , 138.23 (C-2) , 115.04 (C-1) , 60.00 (C-9) , 52.19 (C-5) , 32.07 
(C-3) , 30.75 (C-6) , 28.96 (C-4) ,  20.55 - 20.30 (C-7) , 14.48 (C-10) ppm;  IR (ATR): vmax 2960, 1731, 




To a solution of ester 117a (0.29 g, 1.44 mmol) in MeOH (10 ml) was added NaOH (20% w/w, 2.5 
ml) and reaction was heated to reflux while stirring for 24 hours. Reaction was then cooled to 
room temperature and diluted with H2O (10 ml) and extracted with diethyl ether (20 ml). The 
aqueous layer was acidified to pH 1 with 2M aq. HCl (10 ml), extracted with diethyl ether (3 x 20 
ml). The combined organics were dried with MgSO4, filtered and concentrated in vacuo to give 
116a as a colourless oil (0.23 g, 1.18 mmol, 82% yield).    1H NMR (400 MHz, Chloroform-d): δ 10.77 
(1H, s, COOH), 7.37 – 7.23 (5H, m, Ar-H), 5.75 (1H, dddd, J= 17.0, 10.2, 6.4, 6.4 Hz, H-2), 5.04 – 
4.96 (2H, m, H-1), 3.59 (1H, dd, J = 7.6 Hz, 7.6 Hz H-5), 2.23 – 2.12 (1H, m, H-4), 2.06 – 1.99 (2H, m, 
H- 3), 1.94 – 1.83 (1H, m, H-4) ppm; 13C NMR (101 MHz, Chloroform-d): δ 179.13 ( C-6), 138.79 ( C-
7), 137.33 (C-2 ), 128.78 (C-10), 128.11 (C-9),  127.41 (C-11), 115.60 (C-1), 51.06 (C-5), 31.97 (C-4), 
31.31 (C-3) ppm. IR (ATR) and HRMS (ESI) characterisation was not obtained due to the Spring 
2020 COVID-19 shutdown of laboratory facilities.    
 
   
Compound 116b was synthesised using the same procedure as 116a with ester 1b (416.47 mg, 
2.26 mmol). 116b yielded as a colourless oil (251.53 mg, 1.61 mmol, 71% yield). 1H NMR (400 
MHz, Chloroform-d): δ 11.66 (1H, s, COOH), 5.79 (1H, dddd, J = 17.1 Hz, 10.2 Hz, 6.8 Hz, 6.8 Hz, H-
2), 5.03 (1H, dt, J = 17.6 Hz, 1.9 Hz, H-1), 4.97 (1H, bd, J= 10.4 Hz, H-1), 2.21 – 2.08 (2H, m, H-3, H-
5), 2.07 – 1.96 (1H, m, H-3), 1.90 (1H, dq, J = 13.6 Hz, 6.8 Hz Hz, H-6), 1.77 – 1.67 (1H, m, H-4), 1.63 
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– 1.54 (1H, m, H-4), 0.98 (3H, d, J = 6.7 Hz, H-7), 0.96 (3H, d, J = 6.7 Hz, H-7) ppm; 13C NMR (101 
MHz, Chloroform-d): δ 182.59 (C-8), 137.93 (C-2), 115.26 (C-1), 51.96 (C-5), 31.97 (C-3), 30.51 (C-
6), 28.44 (C-4), 20.48-20.10 (C-7) ppm ; HRMS (ESI): 179.1038 (M+ Na+ , C9H16NaO2 requires 
179.1043). IR (ATR) characterisation was not obtained due to the Spring 2020 COVID-19 shutdown 
of laboratory facilities.    
 
 
To a solution of acid 116a (287.26 mg, 1.51 mmol) in dry toluene (5 ml) under N2 was added Et3N 
(0.32 ml, 1.82 mmol) and DPPA (0.36 ml, 1.66 mmol) and the reaction was heated to 90 °C for 2 
hours. Benzyl alcohol (0.26 ml, 2.27 mmol) was added and reaction was stirred at 90 °C for 48 
hours. The reaction was then quenched with H2O (20 ml) and extracted with EtOAc (2 x 30 ml). 
The combined organics were washed with saturated brine solution (2 x 30 ml), dried with MgSO4, 
filtered and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (10 % EtOAc/hexane) to give 115a as colourless oil (444.5 mg, 1.5 mmol, 99% 
yield).  1H NMR (400 MHz, Chloroform-d): δ 7.32 – 7.14 (10H ,m, H-Ar), 5.73 (1H, dddd, J = 17.1, 
12.2, 6.5, 6.5 Hz, H-2), 5.18 (1H, d, J = 8.0 Hz, N-H),  5.09 – 4.89 (4H, m, H-1,H-11), 4.65 (1H, ddd, J 
= 14.3 , 7.0 Hz, H-5), 2.09 – 1.88 (2H, m , H-3), 1.86 – 1.69 (2H, m, H-4); 13C NMR (101 MHz, 
Chloroform-d): δ  155.0 (C-10), 142.41 (C-6), 137.63 (C-2) , 136.61 (C-12) , 128.5 - 126.3 (C-Ar), 
115.2 (C-1), 66.64 (C-11), 54.8 (C-5), 35.6 (C-4), 30.2 (C-3) ppm;  IR (ATR): vmax 3320, 3064, 2935, 
2854, 1619, 1529, 1496, 1453, 1330, 1289, 1241, 1108, 1027, 911, 748, 696, 483 cm-1 ; HRMS 





Compound 115b was synthesised using the same procedure as 115a with acid 116b (251.53 mg, 
1.61 mmol), Et3N (1.46 ml, 1.93 mmol), DPPA (1.36 ml, 1.77 mmol) and benzyl alcohol (1.00 ml, 
2.41 mmol). 3b yielded as a colourless oil (167.29 mg, 1.07 mmol, 66% yield) after flash column 
chromatography (10 % EtOAc/hexane). 1H NMR (400 MHz, Chloroform-d): δ 7.30 – 7.19 (5H, m, H-
Ar), 5.72 (1H, dddd, J = 16.8 Hz, 10.0 Hz, 6.5 Hz, 6.5 Hz, H-2), 5.00 (2H, s, H-9), 4.91 (1H, d , J = 17.5 
Hz H-1trans), 4.86 (1H, d, J = 9.9 Hz, H-1cis), 4.46 (1H, d, J =8.0 Hz, N-H), 3.45 (1H, ddd, J = 14.3 Hz, 
9.5 Hz, 4.4 Hz, H-5), 2.09 – 1.91 (2H, m, H-3), 1.70 – 1.60 (1H, m, H-6), 1.54 – 1.44 (1H, m, H-4), 
1.33 – 1.22 (1H, m, H-4), 0.82 (3H, d, J = 6.8 Hz, H-7), 0.78 (3H, d, J = 68 Hz, H-7) ppm;  13C NMR 
(101 MHz, Chloroform-d): δ 156.51 (C-8), 138.26 (C-2), 136.81 (C-10), 128.63 (C-12), 128.17 (C-11), 
127.89 (C-13), 114.98 (C-1), 66.69 (C-9), 55.99 (C-5), 32.19 (C-6), 31.90 (C-4), 30.60 (C-3), 19.21 (C-
7), 17.63 (C-7) ppm; HRMS (ESI): 262.1799 (M+H+ . C16H24NO2 requires 262.1802). IR (ATR) 
characterisation was not obtained due to the Spring 2020 COVID-19 shutdown of laboratory 
facilities.    
  
  
To a solution of diisopropylamine (1.54 ml, 11.00 mmol) in dry THF (5 ml) at -78 °C under N2 was 
added n-BuLi (1.81 M , 11.00 mmol) and the solution was stirred for 45 mins. A solution of 
phenylacetonitrile (1.15 ml, 10.00 mmol) in THF (5 ml) was added at -78 °C over 2 minutes and the 
reaction was stirred for 45 mins. Allyl bromide (0.86 ml, 10.00 mmol) was added at -78 °C over 1 
minute and the reaction was warmed to room temperature. The reaction was stirred overnight 
and quenched with 1 M aq. HCl  (10 ml). The reaction was extracted with diethyl ether (3 x 30 ml), 
Organic fractions were combined, washed with saturated brine solution (2 x 30 ml), dried with 
MgSO4, filtered and concentrated in vacuo. The crude residue was purified by flash column 
chromatography (1 % EtOAc/hexane) to give 122 as a colourless oil (583.48 mg, 3.30 mmol, 30% 
yield).  1H NMR (400 MHz, Chloroform-d): δ 7.42 – 7.28 (5H, m, H-Ar), 5.79 (1H, dddd, J = 17.3 Hz, 
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10.5 Hz, 6.9 Hz, 6.9 Hz, H-2), 5.26 – 5.12 (2H, m, H-1), 3.86 (1H, dd, J = 7.12 Hz, 7.12 Hz, H-4), 
2.57–2.47 (2H, m, H-3) ppm; 13C NMR (101 MHz, Chloroform-d): δ 135.39 (C-5), 132.78 (C-2), 
129.20(C-8), 128.28 (C-7), 127.48(C-6), 120.51 (C-9), 119.45 (C-1), 39.92 (C-3), 37.53 (C-4) ppm; IR 
(ATR): vmax 3033, 2921, 2241, 1643, 1600, 1495, 1454, 1077, 994, 925, 754, 698, 623, 554, 510 ; 
HRMS (APCI): 158.096736 (M+ H+ , C11H12N requires 158.096426) 
 
 
  To a suspension of LiAlH4 (188.23 mg , 4.96 mmol) in dry diethyl ether (10 ml) at 0 °C under N2 
was added nitrile 122 (583.00 mg, 3.30 mmol) in dry diethyl ether (10 ml) over 5 mins and the 
reaction was stirred at 0 °C for 30 mins. The reaction was then warmed to room temperature and 
stirred overnight. The reaction was cooled to 0 °C and quenched with H2O (0.2 ml), followed by 
NaOH solution (15% w/w aq, 0.2 ml), followed by H2O (0.6 ml) and then warmed to room 
temperature. MgSO4 was added to the reaction and the suspension was filtered through Celite®. 
The filtrate was concentrated in vacuo to give 121 as a colourless oil (499.97 mg, 3.10 mmol, 93% 
yield). 1H NMR (400 MHz, Chloroform-d): δ 7.54 – 7.05 (5H, m, H-Ar), 5.76 (1H, dddd, J = 17.0 Hz, 
10.0 Hz, 7.0 Hz, 7.0 Hz, H-2), 5.11 – 4.94 (2H, m, H-1), 3.01 (1H, dd, J = 12.6 Hz, 5.1 Hz, H-9), 2.90 
(1H, dd, J = 12.6 Hz, 8.7 Hz, H-9), 2.78 – 2.70 (1H, m, H-4), 2.52 – 2.38 (2H, m, H-3) ppm ; 13C NMR 
(101 MHz, Chloroform-d):  δ 143.10 (C-5), 136.65 (C-2), 128.64 (C-7), 128.05 (C-6), 126.63 (C-8), 
116.25 (C-1), 49.43 (C-4), 47.49 (C-9), 38.48 (C-3) ppm; HRMS (ESI): 162.1278 (M+ H+ , C11H16N 
requires 162.1277). IR (ATR) characterisation was not obtained due to the Spring 2020 COVID-19 





To a solution of  121 (677.25 mg, 4.20 mmol) in dioxane (20 ml) was added K2CO3 solution (696.52 
mg, 5.04 mmol) followed by benzyl chloroformate (1.19 ml, 5.04 mmol) and the reaction was 
stirred at room temperature for 3 hours. The reaction was quenched with H2O (20 ml) and 
extracted with CH2Cl2 (3 x  20 ml). The combined organics were washed with saturated brine 
solution (20 ml), dried with Na2SO4, filtered and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (5 % EtOAc/hexane) to afford 115c as colourless oil 
(876.46 mg, 2.96 mmol, 70% yield).   1H NMR (400 MHz, Chloroform-d): δ 7.35 – 7.07 (10H, m, H-
Ar), 5.63 (1H, ddt, J = 16.9 Hz, 7.2 Hz, H-2),  5.00 (2H, s, H-11), 4.95 (1H, d, J = 17.2 Hz, H-1trans), 
4.91 (1H, d, J = 10.2 Hz H-1cis), 4.63 – 4.51 (1H, m, N-H), 3.62 – 3.54 (1H, m, H-9), 3.20 (1H, ddd, J 
= 13.7 Hz, 9.1 Hz, 4.8 Hz, H-9),  2.82 (1H , apparent pentet , J = 7.5 Hz, H-4),  2.37 – 2.31 (2H, m, H-
3) ppm;  13C NMR (101 MHz, Chloroform-d): δ 156.40 (C-10), 142.08 (C-5), 136.64 (C-12), 135.94 
(C-2), 130.17 – 125.79 (C-Ar), 116.84 (C-1), 66.76 (C-11), 46.10 (C-9), 45.82 (C-4), 38.27 (C-3) ppm; 
HRMS (ESI): 296.1644 (M+H+ , C24H30NO3S requires 296.1645); IR (ATR): vmax 3337, 2926, 1708, 
1520, 1454, 1250, 1141, 999, 756, 699 
 
 
To a solution of NaOH (15% w/w aq., 20 ml) was added NaBH4 (0.04 g, 0.96 mmol) and p-
thiocresol (4 g, 32 mmol) which was then stirred for 3 hours. A solution of butylated 
hydroxytoluene (1.05 g, 0.48 mmol) and acryloyl chloride (3.87 ml, 48 mmol) in cyclohexane (30 
ml) was cooled to 0 °C. The aqueous solution of p-thiocresol was added dropwise to the acyrolyol 
chloride solution and the reaction warmed to room temperature. The reaction was then heated 
to 55 °C for 35 minutes. Then, the reaction was cooled to room temperature and extracted with 
Et2O (2x 80 ml). The combined organics were washed with saturated NaHCO3 solution (100 ml) 
and saturated brine solution (100 ml), dried with MgSO4, filtered and concentrated in vacuo. The 
crude material was purified by column chromatography (2 % Et2O/hexane) to afford 118 as yellow 
oil (3 g, 16mmol, 52% yield). 1H NMR (400 MHz, CDCl3): δ 7.36 (d, J=8.4 Hz, 2H, H-5), 7.26 (d, J=8.4 
Hz, 2H, H-6), 6.48 (dd, J=17.5, 10.0 Hz, 1H, H-2), 6.40 (dd, J=17.5, 1.5 Hz, 1H, H-1), 5.78 (dd, J=10.0, 
1.5 Hz, 1H, H-1), 2.41 (s, 3H, H-8) ppm; 13C NMR (101 MHz, CDCl3): δ 188.9 (C-3), 139.7 (C-7), 134.5 
(C-5), 134.3 (C-2), 130.0 (C-6), 127.2 (C-1), 123.5 (C-4), 21.3 (C-8) ppm; HRMS (ESI) 179.0536 (M + 
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H+. C10H11OS requires 179.0536). IR (ATR) characterisation was not obtained due to the Spring 
2020 COVID-19 shutdown of laboratory facilities.    
 
 
A solution of Cbz-amine 115a (202.92 mg , 0.68 mmol ) in 1,2-DCE (10 ml) and a solution of 
thioester 118 (367.19 mg, 2.06 mmol) in 1,2-DCE (10 ml) were added  under N2 to a dry flask 
containing Hoveyda-Grubbs Catalyst™ 2nd generation ( 43.86 mg, 0.07 mmol) and copper iodide 
(129.50 mg, 0.68 mmol) in 10 ml 1,2-DCE  and the reaction was heated to 50 °C for 24 hours. The 
reaction was cooled to room temperature, and concentrated in vacuo. The crude residue was 
purified by flash column chromatography (15% EtOAc/hexane) to afford 113a as pale yellow oil 
(236.15 mg, 0.53 mmol, 77% yield). 1H NMR (400 MHz, Chloroform-d): δ 7.29 – 7.13 (14H, m, H-
Ar), 6.84 (1H, ddd, J = 14.5 Hz, 6.5 Hz, H-8), 6.07 (1H, d, J = 15.1 Hz, H-7), 5.33 (1H, d, J = 8.2 Hz, N-
H), 5.08 – 4.96 (2H, m, H-17), 4.64 (1H, dd, J = 7.2, 7.2 Hz, H-11), 2.30 (3H, s, H-1), 2.18 – 2.00 (2H, 
m , H-9), 1.93 – 1.74 (2H, m, H-10) ppm; 13C NMR (101 MHz, Chloroform-d): δ 188.57(C-6), 155.93 
(C-16), 145.18 (C-8), 141.88 (C-12), 139.80 (C-2), 136.55 (C-18), 134.97 – 126.26 (C-Ar, C-7), 124.12 
(C-5), 66.99 (C-17), 55.27 (C-11), 34.82 (C-10), 29.27 (C-9), 21.52 (C-1) ppm; IR (ATR): vmax 3031, 






Compound was synthesised using the same procedure as 113a with thioester 118 (342.27 mg, 
1.92 mmol), Hoveyda-Grubbs Catalyst™ 2nd generation (40.10 mg, 0.06 mmol), copper iodide 
(121.8 mg, 0.64 mmol) and Cbz-amine 115b (167.29 mg, 0.64 mmol). 113b yielded as a pale 
yellow oil (218.12 mg, 0.53 mmol, 84% yield) after flash column chromatography (20% 
EtOAc/hexane).  1H NMR (400 MHz, Chloroform-d): δ 7.28 – 7.10 (9H, m, H-Ar), 6.85 (1H, ddd, J = 
14.1 Hz, 6.9 Hz, H-8), 6.17 (1H, d, J = 15.5 Hz, H-7), 5.09 (2H, s, H-15), 4.57 (1H, d, J = 8.0 Hz, N-H), 
3.54 (1H, ddd, J = 14.5 Hz, 9.8 Hz, 4.3 Hz, H-11),  2.37 (3H, s, H-1), 2.34 – 2.17 (2H, m, H-9), 1.79 – 
1.62 (2H, m, H-10, H-12), 1.50 – 1.37 (1H, m, H-11), 0.92 (3H, d, J = 6.8 Hz, H-13), 0.88 (3H, d, J = 
6.8 Hz, H-13) ppm;   13C NMR (101 MHz, CDCl3):  δ 188.61 (C-6), 156.54 (C-14), 145.77 (C-8), 139.73 
(C-15), 136.66 (C-16), 134.73-128.68 (C-Ar), 128.16 (C-7),  124.12 (C-2), 66.87 (C-15), 56.19 (C-11), 
32.40 (C-12), 31.25 (C-10), 29.45 (C-9), 21.48 (C-1), 19.26- 17.71 (C-13) ppm; IR (ATR): vmax 2958, 
1693, 1240, 807; HRMS (ESI): 412.1948 (M+ H+ , C24H30NO3S requires 412.1941) 
 
 
Compound 113c was synthesised using the same procedure as 113a with thioester 118 (361.85 
mg, 2.03 mmol), Hoveyda-Grubbs Catalyst™ 2nd generation (31.33 mg, 0.05 mmol), copper iodide 
(100.36 mg, 0.53 mmol) and Cbz-amine 115c (155.26 mg, 0.53 mmol). 113c yielded as pale yellow 
oil (101.58 mg, 0.22 mmol, 42% yield) after flash column chromatography (20% EtOAc/hexane).  
1H NMR  (400 MHz, Chloroform-d): δ 7.35 – 7.14 (15H, m, H-Ar), 6.83 – 6.74 (1H, ddd, J= 15.0 Hz, 
7.2 Hz,  H-8),  6.13 (1H, d, J = 15.4 Hz, H-7), 5.07 (2H, s, H-17), 4.71 – 4.54 (1H, m, N-H), 3.64 – 3.57 
(1H, m, H-15) , 3.30 (1H, ddd, J = 13.6 Hz, 8.6 Hz, 4.9 Hz, H-15), 3.03 – 2.94 (1H, apparent pentet , J 
= 8.4 Hz, H-10), 2.63 – 2.47 (2H, m, H-9),  2.37 (3H, s, H-1) ppm;  13C NMR (101 MHz, Chloroform-
d): δ 188.37 (C-6), 156.43 (C-16), 143.26 (C-8), 140.88 (C-11), 139.75 (C-2), 136.53 (C-18), 134.68- 
127.30 (C-Ar , C-7), 124.03 (C-5), 66.89 (C-17), 46.25 (C-15), 45.24 (C-10), 36.50 (C-9), 21.47 (C-1) 
ppm; HRMS (ESI): 468.1605 (M+ Na+ , C27H27NNaO3S requires 468.1604). IR (ATR) characterisation 





A solution of 113a (22.28 mg, 0.05 mmol) in 1,2-DCE (5 ml)  was added under N2 to a dry flask 
containing CSA (32.75 mg, 0.14 mmol) and the reaction was heated to 60 oC for 24 hours. The 
reaction was cooled down to room temperature , diluted with saturated NaHCO3 solution (5 ml)  
and extracted with CH2Cl2 (3 x 5 ml). The combined organics were with washed saturated brine 
solution (5 ml), dried with MgSO4, filtered and concentrated in vacuo. The crude material was 
purified by column chromatography (20 % Et2O/hexane) to afford 114a as a colourless oil (11.14 
mg, 0.02 mmol, 61% yield) as a 2:1 mixture of rotomers. 1H NMR (400 MHz, Chloroform-d): δ 7.46 
– 6.79 (14H, m, H-Ar), 5.17 (1H, minor rotamer, d, J=16.0 Hz, H-17), 5.13 (1H, minor rotamer, d, 
J=16.0 Hz, H-17), 5.06-5.00 (1H , both rotomers, m, H-11), 5.01 (1H, major rotamer, d, J=12.0 Hz, 
H-17), 4.87 (1H, major rotamer, d, J=12.0 Hz, H-17), 4.65- 4.55 (1H, m, H-8), 3.47 (1H, major 
rotamer dd, J=3 Hz, 3 Hz, H-7), 3.22 (1H, major rotamer, dd, J=3 Hz, 3Hz,  H-7),  2.81 (1H, minor 
rotamer, dd, J = 9.6 Hz, 9.6 Hz ,H-7), 2.73 (1H, minor rotamer, dd, J= 10.1 Hz, 10.1 Hz, H-7), 2.46 - 
2.32 (4H, m, H-1, H-10), 2.22 - 2.12 (1H, m, H-10), 1.91 – 1.83 (1H, m, H-9), 1.81- 1.78 (1H, m, H-9) 
ppm; 13C NMR (101 MHz, Chloroform-d) δ 194.21 (C-6), 153.84 (C-16), 136.54 – 121.73 (C-
Ar),66.29 (C-17),  61.63 (C-11), 56.08 (C-8), 46.16 (C-7), 32.70 (C-10), 26.73 (C-9), 21.46 (C-1) ppm; 
HRMS(ESI): 446.1786 (M + H+, C27H28NO3S requires 446.1784); IR (ATR) vmax  2924, 1698, 1494, 
1451, 1404, 1347, 1281, 1201, 1114, 1073, 994, 807, 773, 699, 606, 475  
 
 
Compound 114b was synthesised using the same procedure as 114a with 113b (33.08 mg, 0.08 
mmol) and CSA (56.20 mg, 0.24 mmol). 114b yielded as a colourless oil (16.46 mg, 0.04 mmol, 
45% yield) after flash column chromatography (20% EtOAc/hexane) as a 2:1 mixture of rotamers. 
101 
 
1H NMR (400 MHz, Chloroform-d): δ 7.43 – 7.18 (9Η, m, Η-Ar), 5.25 – 5.12 (2H, both rotamers, m, 
H-15), 4.38 – 4.32 (1H, m, H-8), 3.83 – 3.75 (1H, m, H-11), 3.40 (1H, minor rotamer, dd, J = 3.2, 3.2 
Hz, H-7), 3.06 (1H, minor rotamer, dd, J = 3.0, 3.0 Hz, H-7), 2.72 (1H, major rotamer, dd, J = 9.6, 
9.6 Hz, H-7), 2.60 (1H, major rotamer, dd, J = 9.6, 9.9 Hz, H-7), 2.52 – 2.44 (1H, m, H-12), 2.36 (3H, 
s, H-1), 2.26 – 2.20 (2H, m, H-10), 2.08 – 1.95 (2H, m, H-9) ppm; 13C NMR (101 MHz, Chloroform-d) 
δ 196.02 (C-6), 154.17 (C-16), 134.74 – 127.39 (C-Ar), 66.86 (C-15), 63.17 (C-11), 56.05 (C-8), 47.47 
(C-7), 21.49 (C-1) ppm; HRMS (ESI): 434.1768 (M + Na+ , C24H29NNaO3S requires 434.1760). IR 
(ATR) characterisation was not obtained due to the Spring 2020 COVID-19 shutdown of laboratory 
facilities.    
 
 
Compound 114c was synthesised using the same procedure as 114a with 113c (13.36 mg, 0.02 
mmol) and CSA (23.00 mg, 0.98 mmol). 114c yielded as colourless oil (14.00 mg, 0.03 mmol, 90% 
yield) after flash column chromatography (20% EtOAc/hexane). 1H NMR (500 MHz, Chloroform-d): 
δ 7.47 – 7.06 (14H, m, H-Ar), 5.23 – 5.15 (2H, m, H-17), 4.20 – 4.15 (1H, minor rotamer, m, H-15), 
4.09 – 4.04 (1H, major rotamer, m, H-15), 3.58 (1H, dd, J = 2.9, 2.9 Hz, H-7), 3.36 – 3.21 (2H, m, H-
10, H-15), 2.69 – 2.61 (1H, m, H-9), 2.37 (3H, s, H-1), 2.08 – 1.94 (1H, m, H-9) ppm; 13C NMR (126 
MHz, Chloroform-d) δ 195.72 (C-6), 154.61 (C-16), 141.96 – 121.76 (C-Ar), 66.85 (C-17), 55.36 (C-
8), 53.00 (C-15), 47.01 (C-7), 42.95 (C-10), 38.90 (C-9), 21.32 (C-1) ppm;  HRMS (ESI): 446.1795 (M 
+ H+ , C27H28NO3S requires 446.1784). IR (ATR) characterisation was not obtained due to the Spring 









(R)-anth-cat      (R)-3,3’-Bis(9-anthracenyl)-1,1’-binaphthyl-2,2’-diyl hydrogenphosphate 
(R)-FeSulPhos   (Rp)-2-(tert-Butylthio)-1-(diphenylphosphino)ferrocene 
(R)-phen-cat (R)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1’,2’-        
f][1,3,2]dioxaphosphepin-4-oxide 
(R)-TiPSY            (R)-3,3’-Bis(triphenylsilyl)-1,1’-binaphthyl-2,2’-diyl hydrogenphosphate  
(R)-TRIP              (R)-3,3’-Bis(2,4,6-triisopropylphenyl)-1,1’-binaphthyl-2,2’-diyl hydrogenphosphate 
(S)-SEGPHOS     (S)-(−)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole 
1,2-DCE              1,2-dichloroethane 
Å MS                   Ångström molecular sieves 
aq                        aqueous 
Ar                        aryl 
BINOL                 1,1'-bi-2-naphthol 
BiPhePhos         6,6’-*(3,3’-Di-tert-butyl-5-5’-dimethoxy-1,1’-biphenyl-2,2’- 
                            diyl)bis(oxy)]bis(dibenzo[d,f][1,2,3]dioxaphosphenin 
BHT                    butylated hydroxy toluene (2,6-di-t-butyl-4-methylphenol) 
Bn                       benzyl 
Boc                     tert-butyloxycarbonyl 
Bp                       boiling point 
cat.                      catalyst 
Cbz                      carboxybenzyl 
CPA                    chiral phosphoric acid 
CSA                     camphorsulfonic acid 
DABCO               1,4-diazabicyclo[2.2.2]octane  
DBU                    1,8-diazabicyclo[5.4.0]undec-7-ene 
DIAD                  diisopropyl azodicarboxylate 
DME                   dimethoxyethane 
DPPA                 diphenylphosphoryl azide 
dr                       diastereomeric ratio 
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ee                       enantiomeric excess 
eq                       equivalent 
er                       enantiomeric ratio 
ESI                     electrospray ionization 
Et                       ethyl 
Et2O                   diethyl ether 
Et3N                   triethylamine 
EtOAc                ethyl acetate 
FDA                    U.S. Food and Drug Administration 
gem                    geminal 
HPLC                  High Performance Liquid Chromatography  
IPA                     isopropanol 
i-Pr                     isopropyl 
IR                        infra-red 
LDA                    lithium diisopropylamide 
LiHMDS             lithium bis(trimethylsilyl)amide 
Me                     methyl 
MeOH               methanol 
MTBE                methyl tert-butyl ether 
n-Bu                   n-butyl 
NMR                  nuclear magnetic resonance 
Ns                      nitrobenzenesulfonyl 
OAc                   acetate 
OMe                 methoxy  
OTf                    trifluoromethanesulfonate 
PG                      protecting group 
Ph                      phenyl 
rt                        room temperature 
s-Bu                   sec-butyl 
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TBAF                 tetra-n-butylammonium fluoride 
t-Bu                   tert-butyl 
THF                    tetrahydrofuran 
THP                   tetrahydropyran 
TMS                   trimethylsilyl 
Ts                       toluenesulfonyl 
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